BlackBerry Limited (BB) 10-Q 25 Jun 20 2021 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	May 31, 2020	Jun. 22, 2020
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	May 31, 2020
Document Transition Report	false
Entity File Number	001-38232
Entity Registrant Name	BlackBerry Limited
Entity Incorporation, State or Country Code	Z4
Entity Tax Identification Number	98-0164408
Entity Address, Address Line One	2200 University Ave East
Entity Address, City or Town	Waterloo
Entity Address, State or Province	ON
Entity Address, Country	CA
Entity Address, Postal Zip Code	N2K 0A7
City Area Code	(519)
Local Phone Number	888-7465
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		555,754,901
Amendment Flag	false
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q1
Entity Central Index Key	0001070235
Current Fiscal Year End Date	--02-28
NEW YORK STOCK EXCHANGE, INC. [Member]
Document Information [Line Items]
Title of 12(g) Security	Common Shares
Trading Symbol	BB
Security Exchange Name	NYSE

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	May 31, 2020	Feb. 29, 2020
Current
Cash and cash equivalents (note 3)	$ 312	$ 377
Short-term investments (note 3)	562	532
Accounts receivable, net of allowance of $13 and $9, respectively (note 1 and note 4)	210	215
Other receivables	20	14
Income taxes receivable	8	6
Other current assets (note 4)	60	52
Restricted cash and cash equivalents (note 3)	1,172	1,196
Restricted cash and cash equivalents	48	49
Long-term investments (note 3)	33	32
Other long-term assets (note 4)	57	65
Operating lease right-of-use assets, net	118	124
Property, plant and equipment, net (note 4)	66	70
Goodwill (note 4)	843	1,437
Intangible assets, net (note 4)	878	915
Total assets	3,215	3,888
Current
Accounts payable	46	31
Accrued liabilities (note 4)	185	202
Income taxes payable (note 5)	12	18
Short-term Debt, Fair Value	599	606
Deferred revenue, current (note 11)	249	264
Total current liabilities	1,091	1,121
Deferred revenue, non-current (note 11)	92	109
Operating lease liabilities	111	120
Other long-term liabilities (note 4)	8	9
Total liabilities	1,302	1,359
Capital stock and additional paid-in capital
Preferred shares: authorized unlimited number of non-voting, cumulative, redeemable and retractable	0	0
Common shares: authorized unlimited number of non-voting, redeemable, retractable Class A common shares and unlimited number of voting common shares Issued - 555,622,606 voting common shares (February 29, 2020 - 554,199,016)	2,777	2,760
Deficit	(838)	(198)
Accumulated other comprehensive income (loss)	(26)	(33)
Total shareholders' equity	1,913	2,529
Total liabilities and shareholders' equity	$ 3,215	$ 3,888

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	May 31, 2020	Feb. 29, 2020
Statement of Financial Position [Abstract]
Common outstanding (in shares)	555,622,606	554,199,016
Common issued (in shares)	555,622,606	554,199,016
Accounts Receivable, Allowance for Credit Loss	$ 13	$ 9

Consolidated Statements of Shar

Consolidated Statements of Shareholders' Equity - USD ($) $ in Millions	Total	Cumulative Effect, Period of Adoption, Adjustment	Capital Stock and Additional Paid-in Capital	Capital Stock and Additional Paid-in CapitalCumulative Effect, Period of Adoption, Adjustment	Deficit	DeficitCumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive LossCumulative Effect, Period of Adoption, Adjustment
Beginning Balance at Feb. 28, 2019	$ 2,636		$ 2,688		$ (32)		$ (20)
Beginning Balance (Accounting Standards Update 2016-02) at Feb. 28, 2019		$ (14)		$ 0		$ (14)		$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(35)				(35)
Other comprehensive income (loss)	(10)						(10)
Stock-based compensation	17		17
Exercise of stock options	1		1
Employee share purchase plan	2		2
Ending Balance at May. 31, 2019	2,597		2,708		(81)		(30)
Beginning Balance at Feb. 29, 2020	2,529		2,760		(198)		(33)
Beginning Balance (Accounting Standards Update 2016-13) at Feb. 29, 2020		$ (4)		$ 0		$ (4)		$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(636)				(636)
Other comprehensive income (loss)	7						7
Stock-based compensation	13		13
Exercise of stock options	1		1
Employee share purchase plan	3		3
Ending Balance at May. 31, 2020	$ 1,913		$ 2,777		$ (838)		$ (26)

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Millions	3 Months Ended
	May 31, 2020	May 31, 2019
Revenue
Revenues	$ 206	$ 247
Cost of sales
Cost of sales	(63)	(70)
Gross margin	143	177
Operating expenses
Research and development	57	71
Selling, marketing and administration	90	121
Amortization	46	49
Impairment of goodwill	594	0
Debentures fair value adjustment	1	(28)
Total operating expenses	788	213
Operating loss	(645)	(36)
Investment income, net	0	3
Loss before income taxes	(645)	(33)
Provision for (recovery of) income taxes (note 5)	(9)	2
Net loss	$ (636)	$ (35)
Loss per share (note 8)
Earnings (Loss) Per Share, Basic (in usd per share)	$ (1.14)	$ (0.06)
Earnings (Loss) Per Share, Diluted (in usd per share)	$ (1.14)	$ (0.09)

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Millions	3 Months Ended
	May 31, 2020	May 31, 2019
Statement of Comprehensive Income [Abstract]
Net loss	$ (636)	$ (35)
Other comprehensive income (loss)
Net changes in fair value and amounts reclassified to net loss from derivatives designated as cash flow hedges during the period, net of income taxes of nil (May 31, 2019 - income taxes of nil)	(1)	(1)
Foreign currency translation adjustment	1	(1)
Net change in fair value from instrument-specific credit risk on the Debentures, net of income taxes of $1 million (May 31, 2019 - income taxes of nil) (note 6)	7	(8)
Other comprehensive income (loss)	7	(10)
Comprehensive loss	$ (629)	$ (45)

Consolidated Statements of Co_2

Consolidated Statements of Comprehensive Income (Loss) (Parenthetical) - USD ($) $ in Millions	3 Months Ended
	May 31, 2020	May 31, 2019
Statement of Comprehensive Income [Abstract]
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax	$ 0	$ 0
Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, Unrealized Gain (Loss) Arising During Period, Tax	$ 1	$ 0

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	May 31, 2020	May 31, 2019
Cash flows from operating activities
Net loss	$ (636)	$ (35)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Amortization	50	53
Deferred income taxes	0	2
Stock-based compensation	13	17
Impairment of goodwill	594	0
Debentures fair value adjustment	1	(28)
Other long-term liabilities	(1)	0
Operating leases	(3)	(5)
Other	0	2
Net changes in working capital items
Accounts receivable, net	1	(30)
Other receivables	(6)	(4)
Income taxes receivable	(2)	0
Other assets	0	(9)
Accounts payable	15	1
Accrued liabilities	(18)	(57)
Income taxes payable	(7)	2
Deferred revenue	(32)	27
Net cash used in operating activities	(31)	(64)
Cash flows from investing activities
Acquisition of long-term investments	(1)	0
Acquisition of property, plant and equipment	(1)	(2)
Acquisition of intangible assets	(8)	(7)
Business acquisitions, net of cash acquired	0	2
Acquisition of short-term investments	(299)	(392)
Proceeds on sale or maturity of short-term investments	270	270
Net cash used in investing activities	(39)	(129)
Cash flows from financing activities
Issuance of common shares	4	3
Net cash provided by financing activities	4	3
Effect of foreign exchange loss on cash, cash equivalents, restricted cash, and restricted cash equivalents	0	(1)
Net decrease in cash, cash equivalents, restricted cash, and restricted cash equivalents during the period	(66)	(191)
Cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of period	426	582
Cash, cash equivalents, restricted cash, and restricted cash equivalents, end of period	$ 360	$ 391

Blackberry Limited and Summary

Blackberry Limited and Summary of Significant Accounting Policies and Critical Accounting Estimates	3 Months Ended
	May 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Summary of Significant Accounting Policies and Critical Accounting Estimates	1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND CRITICAL ACCOUNTING ESTIMATES Basis of Presentation and Preparation These interim consolidated financial statements have been prepared by management in accordance with United States generally accepted accounting principles (“U.S. GAAP”). They do not include all of the disclosures required by U.S. GAAP for annual financial statements and should be read in conjunction with the audited consolidated financial statements of BlackBerry Limited (the “Company”) for the year ended February 29, 2020 (the “Annual Financial Statements”), which have been prepared in accordance with U.S. GAAP. In the opinion of management, all normal recurring adjustments considered necessary for fair presentation have been included in these interim consolidated financial statements. Operating results for the three months ended May 31, 2020 are not necessarily indicative of the results that may be expected for the full year ending February 28, 2021. The consolidated balance sheet at February 29, 2020 was derived from the audited Annual Financial Statements but does not contain all of the footnote disclosures from the Annual Financial Statements. Certain of the comparative figures have been reclassified to conform to the current period’s presentation. The Company operates as a single reportable segment. For additional information concerning the Company’s segment reporting, see Note 11. Risks and Uncertainties In March 2020, the World Health Organization characterized the novel coronavirus (“COVID-19”) as a global pandemic and extraordinary actions have been taken by international, federal, state, provincial and local governmental authorities to contain and combat the spread of COVID-19 in regions throughout the world. The COVID-19 outbreak and related public health measures, including orders to shelter-in-place, travel restrictions and mandated business closures, have adversely affected workforces, organizations, consumers, economies, and financial markets globally, leading to an economic downturn and increased market volatility. The extent of the impact of COVID-19 on the Company’s operational and financial performance will depend on certain developments, including the duration of the outbreak, impact on the Company’s customers and its sales cycles, and impact on the Company’s employees. The economic downturn and uncertainty caused by the COVID-19 outbreak and the measures undertaken to contain its spread have negatively affected the Company’s QNX automotive software business and has caused volatility in demand for the Company’s products and services, adversely affecting the ability of the Company’s sales and professional services teams to meet with customers and provide service, impacted spending from new customers and increased sales cycle times. The Company continues to evaluate the current and potential impact of the COVID-19 outbreak on its business, results of operations and consolidated financial statements, including the impairment of goodwill and indefinite-lived intangible assets and the collectability of receivables. During the three months ended May 31, 2020, this uncertainty resulted in significant judgment related to the Company’s estimates and assumptions concerning impairment of goodwill and indefinite-lived intangible assets and the collectability of receivables. As of the date of issuance of the financial statements, the Company is not aware of any additional events or circumstances which would require it to update its estimates, judgements, or revise the carrying value of its assets or liabilities, other than the COVID-19 pandemic as discussed above and below in Note 4. These estimates may change, as new events occur and additional information is obtained, and such changes will be recognized in the consolidated financial statements as soon as they become known. Actual results could differ from these estimates and any such differences may be material to the Company’s financial statements. Significant Accounting Policies and Critical Accounting Estimates There have been no material changes to the Company’s accounting policies or critical accounting estimates from those described in the Annual Financial Statements, except as described below, which were adopted during fiscal 2021. Accounting Standards Adopted During Fiscal 2021 ASC 350, Goodwill and Other In January 2017, the Financial Accounting Standards Board (“FASB”) released ASU 2017-04 on the topic of Intangibles— Goodwill and Other (ASC 350). ASU 2017-04 simplifies the subsequent measurement of goodwill, eliminating Step 2 from the goodwill impairment test. Previously, under Step 2, an entity had to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities (including unrecognized assets and liabilities) following the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination. Instead, under the amendments of ASU 2017-04, an entity performs its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. The Company will recognize an impairment charge for any amount by which the carrying amount exceeds the reporting unit’s fair value. The amendments in this update were effective for an entity’s annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. The Company adopted this standard on March 1, 2020. ASC 326, Credit Losses In June 2016, the FASB released ASU 2016-13 on the topic of Financial Instruments — Credit Losses (ASC 326). ASU 2016-13 replaces the previous incurred loss impairment methodology in U.S. GAAP with a methodology that reflects expected credit losses, requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates, and requires entities to estimate an expected lifetime credit loss on its financial assets. The guidance also amends the impairment model for available-for-sale debt securities, requiring entities to determine whether all or a portion of the unrealized loss on such securities is a credit loss, and also eliminating the option for management to consider the length of time a security has been in an unrealized loss position as a factor in concluding whether or not a credit loss exists. The amended model states that an entity recognizes an allowance for credit losses on available-for-sale debt securities, instead of a direct reduction of the amortized cost basis of the investment, as required under previous guidance. As a result, entities recognize improvements to estimated credit losses on available-for-sale debt securities immediately in earnings as opposed to in interest income over time. The guidance was effective for interim and annual periods beginning after December 15, 2019. The Company adopted this guidance in the first quarter of fiscal 2021 using the modified retrospective method. As a result of the adoption of the new standard on credit losses, the Company recorded a cumulative adjustment to the consolidated balance sheet increasing the allowance for credit losses and increasing deficit by approximately $4 million as at March 1, 2020. As a result, the allowance for credit losses was $13 million in the consolidated balance sheet as at March 1, 2020. The following policies have been updated to reflect the adoption of the new standard in accounting for credit losses on financial instruments and goodwill. Goodwill Goodwill represents the excess of the acquisition price in a business combination over the fair value of identifiable net assets acquired. Goodwill is allocated at the date of the business combination. Goodwill is not amortized but is tested for impairment annually on December 31 or more frequently if events or changes in circumstances indicate the asset may be impaired. These events and circumstances may include a significant change in legal factors or in the business climate, a significant decline in the Company’s share price, an adverse action or assessment by a regulator, unanticipated competition, a loss of key personnel, significant disposal activity and the testing of recoverability for a significant asset group. The Company’s impairment test is carried out in one step. The carrying amount of the reporting unit, including goodwill, was compared with its fair value. The estimated fair value was determined utilizing multiple approaches based on the nature of the reporting units being valued. In its analysis, the Company utilized multiple valuation techniques, including the income approach, discounted future cash flows, the market-based approach, and the asset value approach. The analysis requires significant judgment, including estimation of future cash flows, which is dependent on internal forecasts, estimation of the long-term rate of revenue growth for our reporting units, estimation of the useful life over which cash flows will occur, terminal growth rate, profitability measures, and determination of the discount rates for the reporting units. The carrying amount of the Company’s assets was assigned to reporting units using reasonable methodologies based on the asset type. When the carrying amount of a reporting unit exceeds its fair value, goodwill of the reporting unit is considered to be impaired and written down to its fair value. Different judgments could yield different results. Events and circumstances resulted in a goodwill impairment test being conducted as at May 31, 2020; see Note 4. Accounts receivable, net The accounts receivable balance reflects invoiced and accrued revenue and is presented net of an allowance for credit losses. The Company expects the majority of its accounts receivable balances to continue to come from large customers as it sells the majority of its software products and services through resellers and network carriers rather than directly. The Company establishes current expected credit losses (“CECL”) for pools of assets with similar risk characteristics by evaluating historical levels of credit losses, current economic conditions that may affect a customer’s ability to pay, and creditworthiness of significant customers. When specific customers are identified as no longer sharing the same risk profile as their current pool, they are removed from the pool and evaluated separately. The Company, in the normal course of business, monitors the financial condition of its customers and reviews the credit history of each new customer. When the Company becomes aware of a specific customer’s inability to meet its financial obligations to the Company (such as in the case of bankruptcy filings or material deterioration in the customer’s operating results or financial position, and payment experiences), the Company records a specific credit loss provision to reduce the customer’s related accounts receivable to its estimated net realizable value. If circumstances related to specific customers change, the Company’s estimates of the recoverability of accounts receivable balances could be further adjusted. Investments The Company’s cash equivalents and investments, other than publicly issued equity securities and private equity investments without readily determinable fair value, consist of money market and other debt securities, which are classified as available-for-sale for accounting purposes and are carried at fair value. Unrealized gains and losses, net of related income taxes, are recorded in Accumulated Other Comprehensive Loss (“AOCL”) until such investments mature or are sold. The Company uses the specific identification method of determining the cost basis in computing realized gains or losses on available-for-sale investments, which are recorded in investment income. The Company does not exercise significant influence with respect to any of these investments. Publicly issued equity securities are recorded at fair value and revalued at each reporting period with changes in fair value recorded through investment income. The Company elects to record private equity investments without readily determinable fair value at cost minus impairment, as adjusted for any changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer. The Company reassesses each reporting period that its private equity investments without readily determinable fair value continue to qualify for this treatment. Investments with maturities at the time of purchase of three months or less are classified as cash equivalents. Investments with maturities of one year or less (but which are not cash equivalents), public equity investments and any investments that the Company intends to hold for less than one year are classified as short-term investments. Investments with maturities in excess of one year or investments that the Company does not intend to sell are classified as long-term investments. Allowance for Credit Losses on Available-for-sales Debt Securities The Company accounts for credit losses on available-for-sale debt securities in accordance with ASC 326. The Company adopted ASC 326 on March 1, 2020, on a modified retrospective basis. Under ASC 326, at each reporting period, the Company evaluates its available-for-sale debt securities at the individual security level to determine whether there is a decline in the fair value below its amortized cost basis (an impairment). In circumstances where the Company intends to sell, or is more likely than not required to sell, the security before it recovers its amortized cost basis, the difference between fair value and amortized cost is recognized as a loss in the consolidated statement of operations, with a corresponding write-down of the security’s amortized cost. In circumstances where neither condition exists, the Company then evaluates whether a decline is due to credit-related factors. The factors considered in determining whether a credit loss exists can include the extent to which fair value is less than the amortized cost basis, changes in the credit quality of the underlying issuer, credit ratings actions, as well as other factors. To determine the portion of a decline in fair value that is credit-related, the Company compares the present value of the expected cash flows of the security discounted at the security’s effective interest rate to the amortized cost basis of the security. A credit-related impairment is limited to the difference between fair value and amortized cost, and recognized as an allowance for credit loss on the consolidated balance sheet with a corresponding adjustment to net income. Any remaining decline in fair value that is non-credit related is recognized in other comprehensive income (loss), net of tax. Improvements in expected cash flows due to improvements in credit are recognized through reversal of the credit loss and corresponding reduction in the allowance for credit loss. Government Subsidies The Company recognizes government subsidies as a reduction to operating expenses in the consolidated statement of operations when there is reasonable assurance the Company will receive the amount and has complied with the conditions, if any, attached to the government subsidies.

Accounting Pronouncements Not Y

Accounting Pronouncements Not Yet Adopted	3 Months Ended
	May 31, 2020
Accounting Policies [Abstract]
Accounting Pronouncements Not Yet Adopted	ACCOUNTING PRONOUNCEMENTS NOT YET ADOPTEDThere are no accounting pronouncements which have not yet been adopted that are expected to have a significant impact on the Company’s financial statements and related disclosures.

Fair Value Measurements, Cash,

Fair Value Measurements, Cash, Cash Equivalents and Investments	3 Months Ended
	May 31, 2020
Cash and Cash Equivalents [Abstract]
Fair Value Measurements, Cash, Cash Equivalents and Investments	FAIR VALUE MEASUREMENTS, CASH, CASH EQUIVALENTS AND INVESTMENTS Fair Value The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use in pricing the asset or liability, such as inherent risk, non-performance risk and credit risk. The Company applies the following fair value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value into three levels: • Level 1 - Unadjusted quoted prices at the measurement date for identical assets or liabilities in active markets. • Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data. • Level 3 - Significant unobservable inputs that are supported by little or no market activity. The fair value hierarchy also requires the Company to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Recurring Fair Value Measurements The Company’s cash and cash equivalents, accounts receivable, other receivables, accounts payable and accrued liabilities are measured at an amount that approximates their fair values (Level 2 measurement) due to their short maturities. In determining the fair value of investments held, the Company primarily relies on an independent third-party valuator for the fair valuation of securities. The Company also reviews the inputs used in the valuation process and assesses the pricing of the securities for reasonableness after conducting its own internal collection of quoted prices from brokers. Fair values for all investment categories provided by the independent third-party valuator that are in excess of 0.5% from the fair values determined by the Company are communicated to the independent third-party valuator for consideration of reasonableness. The independent third-party valuator considers the information provided by the Company before determining whether a change in their original pricing is warranted. The Company’s investments largely consist of securities issued by major corporate and banking organizations, the provincial and federal governments of Canada, international government banking organizations and the United States Department of the Treasury and are all investment grade. The Company also holds a limited amount of equity securities following the initial public offering by the issuer of a previous private equity investment. Cash, Cash Equivalents and Investments The components of cash, cash equivalents and investments by fair value level as at May 31, 2020 were as follows: Cost Basis Unrealized Unrealized Other-than- Fair Value Cash and Short-term Long-term Restricted Cash Bank balances $ 120 $ — $ — $ — $ 120 $ 120 $ — $ — $ — Other investments 33 — — — 33 — — 33 — 153 — — — 153 120 — 33 — Level 1: Equity securities 10 — (8) — 2 — 2 — — Level 2: Corporate notes/bonds 37 — — — 37 37 — — — Term deposits, certificates of deposits, and GICs 108 — — — 108 10 50 — 48 Bearer deposit notes 131 — — — 131 79 52 — — Commercial paper 289 — — — 289 62 227 — — Non-U.S. promissory notes 172 — — — 172 4 168 — — Non-U.S. government sponsored enterprise notes 38 — — — 38 — 38 — — Non-U.S. treasury bills/notes 25 — — — 25 — 25 — — 800 — — — 800 192 560 — 48 $ 963 $ — $ (8) $ — $ 955 $ 312 $ 562 $ 33 $ 48 The components of cash, cash equivalents and investments by fair value level as at February 29, 2020 were as follows: Cost Basis Unrealized Unrealized Other-than- Fair Value Cash and Short-term Long-term Restricted Cash and Cash Equivalents Bank balances $ 100 $ — $ — $ — $ 100 $ 100 $ — $ — $ — Other investments 32 — — — 32 — — 32 — 132 — — — 132 100 — 32 — Level 1: Equity securities 10 — (8) — 2 — 2 — — Level 2: Term deposits, certificates of deposits, and GICs 118 — — — 118 44 25 — 49 Bankers’ acceptances/bearer deposit notes 84 — — — 84 30 54 — — Commercial paper 276 — — — 276 108 168 — — Non-U.S. promissory notes 133 — — — 133 25 108 — — Non-U.S. government sponsored enterprise notes 144 — — — 144 — 144 — — Non-U.S. treasury bills/notes 56 — — — 56 25 31 — — U.S. treasury bills/notes 45 — — — 45 45 — — — 856 — — — 856 277 530 — 49 $ 998 $ — $ (8) $ — $ 990 $ 377 $ 532 $ 32 $ 49 As at May 31, 2020, the Company had private equity investments without readily determinable fair value of $33 million (February 29, 2020 - $32 million). There were no realized gains or losses on available-for-sale securities for the three months ended May 31, 2020 (realized losses of nil for the three months ended May 31, 2019). The Company has restricted cash and cash equivalents, consisting of cash and securities pledged as collateral to major banking partners in support of the Company’s requirements for letters of credit. These letters of credit support certain leasing arrangements entered into in the ordinary course of business and also support patent litigation in certain jurisdictions. The letters of credit are for terms ranging from one five The following table provides a reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents as at May 31, 2020 and February 29, 2020 from the consolidated balance sheets to the consolidated statements of cash flows: As at May 31, 2020 February 29, 2020 Cash and cash equivalents $ 312 $ 377 Restricted cash and cash equivalents 48 49 Total cash, cash equivalents, restricted cash, and restricted cash equivalents presented in the consolidated statements of cash flows $ 360 $ 426 The contractual maturities of available-for-sale investments as at May 31, 2020 and February 29, 2020 were as follows: As at May 31, 2020 February 29, 2020 Cost Basis Fair Value Cost Basis Fair Value Due in one year or less $ 800 $ 800 $ 856 $ 856 No fixed maturity 10 2 10 2 $ 810 $ 802 $ 866 $ 858

Consolidated Balance Sheets Det

Consolidated Balance Sheets Details	3 Months Ended
	May 31, 2020
Balance Sheet Related Disclosures [Abstract]
Consolidated Balance Sheet Details	CONSOLIDATED BALANCE SHEET DETAILS Accounts Receivable, Net The allowance for credit losses as at May 31, 2020 was $13 million (February 29, 2020 - $9 million). The Company recognizes current estimated credit losses for accounts receivable, net. The CECL for accounts receivable, net are estimated based on days past due and region for each customer in relation to a representative pool of assets consisting of a large number of customers with similar risk characteristics that operate under similar economic environments. The Company determined the CECL by estimating historical credit loss experience based on the past due status and region of the customers, adjusted as appropriate to reflect current conditions and estimates of future economic conditions, inclusive of the effect of the COVID-19 pandemic on credit losses. The duration and severity of COVID-19 and continued market volatility is highly uncertain and, as such, the impact on expected credit losses is subject to significant judgment and may cause variability in the Company’s allowance for credit losses in future periods. When specific customers are identified as no longer sharing the same risk profile as their current pool, they are removed from the pool and evaluated separately. The Company also has long-term accounts receivable included in Other Long-term Assets. The CECL for long-term accounts receivable is estimated using the probability of default method and the default exposure due to limited historical information. The exposure of default is represented by the assets’ amortized carrying amount at the reporting date. The following table sets forth the activity in the Company’s allowance for credit losses: Three Months Ended May 31, 2020 Beginning balance as of February 29, 2020 $ 9 Impact of adopting ASC 326 4 Current period provision for expected credit losses — Ending balance of the allowance for credit loss as at May 31, 2020 $ 13 The allowance for credit losses as at May 31, 2020 consists of $6 million relating to CECL estimated based on days past due and region, $6 million relating to specific customers that were evaluated separately and $1 million relating to CECL estimated for long-term accounts receivables. There were two customers that comprised more than 10% of accounts receivable as at May 31, 2020 (February 29, 2020 - two customers comprised more than 10%). Other Current Assets As at May 31, 2020, other current assets include items such as the current portion of deferred commissions and prepaid expenses, among other items, none of which were greater than 5% of the current assets balance in all periods presented. Property, Plant and Equipment, Net Property, plant and equipment comprised the following: As at May 31, 2020 February 29, 2020 Cost Buildings, leasehold improvements and other $ 72 $ 72 BlackBerry operations and other information technology 82 84 Manufacturing, repair and research and development equipment 73 73 Furniture and fixtures 11 11 238 240 Accumulated amortization 172 170 Net book value $ 66 $ 70 Intangible Assets, Net Intangible assets comprised the following: As at May 31, 2020 Cost Accumulated Net Book Acquired technology $ 1,020 $ 656 $ 364 Intellectual property 493 284 209 Other acquired intangibles 494 189 305 $ 2,007 $ 1,129 $ 878 As at February 29, 2020 Cost Accumulated Net Book Acquired technology $ 1,019 $ 636 $ 383 Intellectual property 489 275 214 Other acquired intangibles 494 176 318 $ 2,002 $ 1,087 $ 915 For the three months ended May 31, 2020, amortization expense related to intangible assets amounted to $45 million (three months ended May 31, 2019 - $47 million) Total additions to intangible assets for three months ended May 31, 2020 amounted to $8 million (three months ended May 31, 2019 - $7 million). During the three months ended May 31, 2020, additions to intangible assets primarily consisted of payments for intellectual property relating to patent maintenance, registration and license fees. Based on the carrying value of the identified intangible assets as at May 31, 2020, and assuming no subsequent impairment of the underlying assets, the annual amortization expense for the remainder of fiscal 2021 and each of the five succeeding years is expected to be as follows: fiscal 2021 - $126 million; fiscal 2022 - $145 million; fiscal 2023 - $115 million; fiscal 2024 - $107 million; fiscal 2025 - $101 million and fiscal 2026 - $95 million. Goodwill Changes to the carrying amount of goodwill during the three months ended May 31, 2020 were as follows: Carrying Amount Carrying amount as at February 29, 2020 1,437 Goodwill impairment charge (594) Carrying amount as at May 31, 2020 $ 843 During the first quarter of fiscal 2021, as a result of the deterioration in economic conditions caused by the global COVID-19 pandemic and its impact on the Company’s reporting units, and the decline of the trading value of the Company’s capital stock below the Company’s consolidated carrying value, the Company determined that it was more likely than not that the fair value of at least one of its reporting units was lower than its carrying amount after including goodwill. As a result, the Company completed an analysis of the fair value of its reporting units to compare against their respective carrying values as of May 31, 2020. In its analysis, the Company utilized multiple valuation techniques, including the income approach, discounted future cash flows, the market-based approach, and the asset value approach which is based on the sum of the values of each of the assets and liabilities within the entity. In addition to market data, the valuation techniques utilize Level 3 inputs such as the Company’s internal forecasts of its future results, cash flows and its weighted average cost of capital, which is risk-adjusted to reflect the specific risk profile of the reporting unit being tested and based upon the Company’s estimated credit rating. The analysis involves significant judgment in the selection of assumptions necessary to arrive at the reporting units’ fair values, especially in light of the ongoing COVID-19 pandemic and its short-term and potential long-term impacts to the Company’s business. The total of the fair values of the Company’s reporting units was reconciled to the Company’s market capitalization based on the quoted market price of the Company’s stock in an active market, adjusted by an appropriate control premium. Where the carrying amount of a reporting unit exceeded its fair value, goodwill of the reporting unit was considered to be impaired. Based on the results of the goodwill impairment test, it was concluded that the carrying value of one reporting unit exceeded its fair value, necessitating an impairment charge for the amount of excess and reducing the carrying value of Goodwill. Consequently, the Company recorded total non-cash goodwill impairment charges of $594 million in the BlackBerry Spark reporting unit (the “Goodwill Impairment Charge”). Other Long-term Assets As at May 31, 2020, other long-term assets include long-term portion of deferred commission and long-term receivables, among other items, none of which were greater than 5% of total assets in any of the periods presented. Accrued Liabilities Accrued liabilities includes the current portion of operating lease liabilities, accrued vendor liabilities, accrued carrier liabilities, variable incentive accrual and payroll withholding taxes, among other items, none of which were greater than 5% of the current liabilities balance. Other Long-term Liabilities Other long-term liabilities consist of the long-term portion of finance lease liabilities and non-lease components of Resource Allocation Program liabilities.

Income Taxes

Income Taxes	3 Months Ended
	May 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	INCOME TAXES For the three months ended May 31, 2020, the Company’s net effective income tax recovery rate was approximately 1% compared to a net effective income tax expense rate of 6% for the three months ended May 31, 2019. The Company’s income tax rate reflects the change in unrecognized income tax benefit and the fact that the Company has a significant valuation allowance against its deferred income tax assets, and in particular, the change in fair value of the Debentures, amongst other items, is offset by a corresponding adjustment of the valuation allowance. The Company’s net effective income tax rate also reflects the geographic mix of earnings in jurisdictions with different income tax rates. The Company’s total unrecognized income tax benefits as at May 31, 2020 were $61 million (February 29, 2020 - $72 million). As at May 31, 2020, $55 million of the unrecognized income tax benefits have been netted against deferred income tax assets and $6 million has been recorded within income taxes payable on the Company’s consolidated balance sheets. The Company is subject to ongoing examination by tax authorities in certain jurisdictions in which it operates. The Company regularly assesses the status of these examinations and the potential for adverse outcomes to determine the adequacy of the provision for income taxes as well as the provisions for indirect and other taxes and related penalties and interest. While the final resolution of audits is uncertain, the Company believes the ultimate resolution of these audits will not have a material adverse effect on its consolidated financial position, liquidity or results of operations.

Debentures

Debentures	3 Months Ended
	May 31, 2020
Debt Disclosure [Abstract]
Debentures	DEBENTURES On September 7, 2016, Fairfax Financial Holdings Limited (“Fairfax”) and other institutional investors invested in the Company through a private placement of new debentures in an aggregate amount of $605 million (the “Debentures”). Interest on the Debentures is payable quarterly in arrears at a rate of 3.75% per annum. The Debentures mature on November 13, 2020, and each $1,000 of Debentures is convertible at any time into 100 common shares of the Company, for a total of 60.5 million common shares at a price of $10.00 per share for all Debentures, subject to adjustments. Covenants associated with the Debentures include limitations on the Company’s total indebtedness. Under specified events of default, the outstanding principal and any accrued interest on the Debentures become immediately due and payable upon request of holders holding not less than 25% of the principal amount of the Debentures then outstanding. During an event of default, the interest rate rises to 7.75% per annum. The Debentures are subject to a change of control provision whereby the Company would be required to make an offer to repurchase the Debentures at 115% of par value if a person or group (not affiliated with Fairfax) acquires 35% of the Company’s outstanding common shares, acquires all or substantially all of its assets, or if the Company merges with another entity and the Company’s existing shareholders hold less than 50% of the common shares of the surviving entity. The following table summarizes the change in fair value of the Debentures for the three months ended May 31, 2020: As at May 31, 2020 Balance as at February 29, 2020 606 Change in fair value of the Debentures (7) Balance as at May 31, 2020 $ 599 The difference between the fair value of the Debentures and the unpaid principal balance of $605 million is $6 million. The fair value of the Debentures is measured using Level 2 fair value inputs. The following table shows the impact of the changes in fair value of the Debentures for the three months ended May 31, 2020 and May 31, 2019: Three Months Ended May 31, 2020 May 31, 2019 Income (charge) associated with the change in fair value from non-credit components recorded in the consolidated statements of operations $ (1) $ 28 Income (charge) associated with the change in fair value from instrument-specific credit components recorded in AOCL 8 (8) Total decrease (increase) in the fair value of the Debentures $ 7 $ 20 For the three months ended May 31, 2020, the Company recorded interest expense related to the Debentures of $6 million, which has been included in investment income, net on the Company’s consolidated statements of operations (three months ended May 31, 2019 - $6 million). The Company is required to make quarterly interest-only payments of approximately $6 million in the second quarter of fiscal 2021 and approximately $5 million in the third quarter of fiscal 2021 when the Debentures mature.

Capital Stock

Capital Stock	3 Months Ended
	May 31, 2020
Equity [Abstract]
Capital Stock	CAPITAL STOCK The following details the changes in issued and outstanding common shares for the three months ended May 31, 2020: Capital Stock and Stock Amount Common shares outstanding as at February 29, 2020 554,199 2,760 Exercise of stock options 300 1 Common shares issued for restricted share unit settlements 325 — Stock-based compensation — 13 Common shares issued for employee share purchase plan 799 3 Common shares outstanding as at May 31, 2020 555,623 $ 2,777 The Company had 556 million voting common shares outstanding, 5 million options to purchase voting common shares, 24 million RSUs and 1 million DSUs outstanding as at June 22, 2020. In addition, 60.5 million common shares are issuable upon conversion in full of the Debentures as described in Note 6.

Earnings (Loss) Per Share

Earnings (Loss) Per Share	3 Months Ended
	May 31, 2020
Earnings Per Share [Abstract]
Earnings (Loss) Per Share	LOSS PER SHARE The following table sets forth the computation of basic and diluted loss per share: Three Months Ended May 31, 2020 May 31, 2019 Net loss for basic and diluted loss per share available to common shareholders $ (636) $ (35) Less: Debentures fair value adjustment (1) (2) — (28) Add: interest expense on Debentures (1) (2) — 6 Net loss for diluted loss per share available to common shareholders $ (636) $ (57) Weighted average number of shares outstanding (000’s) - basic (3) (4) 557,839 551,845 Effect of dilutive securities (000’s) Conversion of Debentures (1) (2) — 60,500 Weighted average number of shares and assumed conversions (000’s) diluted 557,839 612,345 Loss per share - reported Basic $ (1.14) $ (0.06) Diluted $ (1.14) $ (0.09) ______________________________ (1) The Company has not presented the dilutive effect of the Debentures using the if-converted method in the calculation of diluted loss per share for the three months ended May 31, 2020, as to do so would be antidilutive. See Note 6 for details on the Debentures. (2) The Company has presented the dilutive effect of the Debentures using the if-converted method, assuming conversion at the beginning of the quarter for the three months ended May 31, 2019. Accordingly, to calculate diluted loss per share, the Company adjusted net loss by eliminating the fair value adjustment made to the Debentures and interest expense incurred on the Debentures in the three months ended May 31, 2019, and added the number of shares that would have been issued upon conversion to the diluted weighted average number of shares outstanding. See Note 6 for details on the Debentures. (3) For the three months ended May 31, 2020, includes approximately 2,802,067 common shares remaining to be issued in equal installments on the next two anniversary dates of the Cylance acquisition, in consideration for the acquisition. For the three months ended May 31, 2019, includes approximately 4,182,189 common shares to be issued in equal installments on the three anniversary dates of the Cylance acquisition, in consideration for the acquisition. There are no service or other requirements associated with the issuance of these shares. (4) The Company has not presented the dilutive effect of in-the-money options and RSUs that will be settled upon vesting by the issuance of new common shares in the calculation of diluted loss per share for the three months ended May 31, 2020, and three months ended May 31, 2019, as to do so would be antidilutive.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	3 Months Ended
	May 31, 2020
Equity [Abstract]
Accumulated Other Comprehensive Loss	ACCUMULATED OTHER COMPREHENSIVE LOSS The changes in AOCL by component net of tax, for the three months ended May 31, 2020 were as follows: Foreign Currency Cumulative Translation Adjustment Accumulated Net Unrealized Losses on Cash Flow Hedges Other Post-Employment Benefit Obligations Change in fair value from instrument-specific credit risk on Debentures Total AOCL as at February 29, 2020 $ (9) $ (1) $ (1) $ (22) $ (33) Other comprehensive income before reclassification 1 $ 1 $ — 7 $ 9 Amounts reclassified from AOCL into net loss — (2) — — (2) Change in cumulative comprehensive income (loss) for the period 1 (1) — 7 7 AOCL as at May 31, 2020 $ (8) $ (2) $ (1) $ (15) $ (26)

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	May 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	COMMITMENTS AND CONTINGENCIES (a) Letters of Credit The Company had $48 million in collateralized outstanding letters of credit in support of certain leasing arrangements entered into in the ordinary course of business and in support of patent litigation in certain jurisdictions as of May 31, 2020. See the discussion of restricted cash in Note 3. (b) Contingencies Litigation The Company is involved in litigation in the normal course of its business, both as a defendant and as a plaintiff. The Company is subject to a variety of claims (including claims related to patent infringement, purported class actions and other claims in the normal course of business) and may be subject to additional claims either directly or through indemnities against claims that it provides to certain of its partners and customers. In particular, the industry in which the Company competes has many participants that own, or claim to own, intellectual property, including participants that have been issued patents and may have filed patent applications or may obtain additional patents and proprietary rights for technologies similar to those used by the Company in its products. The Company has received, and may receive in the future, assertions and claims from third parties that the Company’s products infringe on their patents or other intellectual property rights. Litigation has been, and will likely continue to be, necessary to determine the scope, enforceability and validity of third-party proprietary rights or to establish the Company’s proprietary rights. Regardless of whether claims against the Company have merit, those claims could be time-consuming to evaluate and defend, result in costly litigation, divert management’s attention and resources, subject the Company to significant liabilities and could have the other effects that are described in greater detail under Part I, Item 1A “Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended February 29, 2020, including the risk factors entitled “Litigation against the Company may result in adverse outcomes” and “The Company could be found to have infringed on the intellectual property rights of others”. Management reviews all of the relevant facts for each claim and applies judgment in evaluating the likelihood and, if applicable, the amount of any potential loss. Where a potential loss is considered probable and the amount is reasonably estimable, provisions for loss are made based on management’s assessment of the likely outcome. Where a range of loss can be reasonably estimated with no best estimate in the range, the Company records the minimum amount in the range. The Company does not provide for claims for which the outcome is not determinable or claims for which the amount of the loss cannot be reasonably estimated. Any settlements or awards under such claims are provided for when reasonably determinable. As of May 31, 2020, there are no material claims outstanding for which the Company has assessed the potential loss as both probable to result and reasonably estimable; therefore, no material accrual has been made. Further, there are claims outstanding for which the Company has assessed the potential loss as reasonably probable to result; however, an estimate of the amount of loss cannot reasonably be made. There are many reasons that the Company cannot make these assessments, including, among others, one or more of the following: the early stages of a proceeding does not require the claimant to specifically identify the patent claims that have allegedly been infringed or the products that are alleged to infringe; damages sought are unspecified, unsupportable, unexplained or uncertain; discovery has not been started or is incomplete; the facts that are in dispute are highly complex (e.g., once a patent is identified, the analysis of the patent and a comparison to the activities of the Company is a labour-intensive and highly technical process); the difficulty of assessing novel claims; the parties have not engaged in any meaningful settlement discussions; the possibility that other parties may share in any ultimate liability; and the often slow pace of litigation. Though they do not meet the test for accrual described above, the Company has included the following summaries of certain of its legal proceedings that it believes may be of interest to its investors. Between October and December 2013, several purported class action lawsuits and one individual lawsuit were filed against the Company and certain of its former officers in various jurisdictions in the U.S. and Canada alleging that the Company and certain of its officers made materially false and misleading statements regarding the Company’s financial condition and business prospects and that certain of the Company’s financial statements contain material misstatements. The individual lawsuit was voluntarily dismissed. On March 14, 2014, the four putative U.S. class actions were consolidated in the U.S. District Court for the Southern District of New York, and on May 27, 2014, a consolidated amended class action complaint was filed. On March 13, 2015, the Court issued an order granting the Company’s motion to dismiss. The Court denied the plaintiffs’ motion for reconsideration and for leave to file an amended complaint on November 13, 2015. On August 24, 2016, the U.S. Court of Appeals for the Second Circuit affirmed the District Court order dismissing the complaint, but vacated the order denying leave to amend and remanded to the District Court for further proceedings in connection with the plaintiffs’ request for leave to amend. The Court granted the plaintiffs’ motion for leave to amend on September 13, 2017. On September 29, 2017, the plaintiffs filed a second consolidated amended class action complaint (the “Second Amended Complaint”), which added the Company’s former Chief Legal Officer as a defendant. The Court denied the motion to dismiss the Second Amended Complaint on March 19, 2018. On January 4, 2019, the Court issued an order placing the case on its suspense calendar but allowed fact and expert discovery to continue. On August 2, 2019, the Magistrate Judge issued a Report and Recommendation that the Court grant the defendants’ motion for judgment on the pleadings dismissing the claims of additional plaintiffs Cho and Ulug. On September 24, 2019, the District Court Judge accepted the Magistrate Judge’s recommendation and dismissed the claims of Cho and Ulug against all defendants. On October 17, 2019, Cho and Ulug filed a Notice of Appeal. Cho and Ulug filed their opening brief on February 20, 2020, and the Company filed its opposition brief on May 21, 2020. Fact discovery was completed on January 31, 2020, and expert discovery is scheduled to be completed on November 13, 2020. Plaintiffs filed a motion for class certification on June 8, 2020. On July 23, 2014, the plaintiffs in the putative Ontario class action filed a motion for certification and leave to pursue statutory misrepresentation claims. On November 16, 2015, the Ontario Superior Court of Justice issued an order granting the plaintiffs’ motion for leave to file a statutory claim for misrepresentation. On December 2, 2015, the Company filed a notice of motion seeking leave to appeal this ruling. On January 22, 2016, the Court postponed the hearing on the plaintiffs’ certification motion to an undetermined date after asking the Company to file a motion to dismiss the claims of the U.S. plaintiffs for forum non conveniens. Before that motion was heard, the parties agreed to limit the class to purchasers who reside in Canada or purchased on the Toronto Stock Exchange. On November 15, 2018, the Court denied the Company’s motion for leave to appeal the order granting the plaintiffs leave to file a statutory claim for misrepresentation. On February 5, 2019, the Court entered an order certifying a class comprised persons (a) who purchased BlackBerry common shares between March 28, 2013, and September 20, 2013, and still held at least some of those shares as of September 20, 2013, and (b) who acquired those shares on a Canadian stock exchange or acquired those shares on any other stock exchange and were a resident of Canada when the shares were acquired. Notice of class certification was published on March 6, 2019. The Company filed its Statement of Defence on April 1, 2019, and discovery is proceeding. On February 15, 2017, a putative employment class action was filed against the Company in the Ontario Superior Court of Justice. The Statement of Claim alleges that actions the Company took when certain of its employees decided to accept offers of employment from Ford Motor Company of Canada amounted to a wrongful termination of the employees’ employment with the Company. The claim seeks (i) an unspecified quantum of statutory, contractual, or common law termination entitlements; (ii) punitive or breach of duty of good faith damages of CAD$20,000,000, or such other amount as the Court finds appropriate, (iii) pre- and post- judgment interest, (iv) attorneys’ fees and costs, and (v) such other relief as the Court deems just. The Court granted the plaintiffs’ motion to certify the class action on May 27, 2019. The Company commenced a motion for leave to appeal the certification order on June 11, 2019. The Court denied the motion for leave to appeal on September 17, 2019. On February 4, 2019, a putative employment class action and California Private Attorney General Act claim was filed against the Company in the San Joaquin County Superior Court alleging the Company (i) failed to provide itemized wage statements in violation of California Labor Code Section 226(a); and (ii) failed to pay all wages due at termination in violation of California Labor Code Section 201. The complaint seeks statutory penalties, injunctive relief, interest, costs, and attorneys’ fees. The Company filed its answer denying the allegations in the complaint on March 18, 2019, and discovery is proceeding. On August 22, 2019, the Company filed a Motion for Summary Adjudication of the named plaintiff’s wage statement claims. The Court took the motion under submission following oral argument on November 13, 2019, and the motion remains pending. The Court denied the motion on January 21, 2020. The parties have entered into a settlement agreement that is subject to Court approval. The plaintiff filed a motion for preliminary approval of the settlement on June 11, 2020, and the preliminary approval hearing is scheduled for July 16, 2020. The parties will provide notice of the settlement to the class after the Court enters its order preliminarily approving the settlement. Other contingencies In the first quarter of fiscal 2019, the Board approved a compensation package for the Company’s Executive Chair and CEO as an incentive to remain as Executive Chair until November 23, 2023. As part of the package, the Company’s Executive Chair and CEO is entitled to receive a contingent performance-based cash award in the amount of $90 million that will become earned and payable should the 10-day average closing price of the Company’s common shares on the New York Stock Exchange reach $30 before November 3, 2023. As the award is triggered by the Company’s share price, it is considered stock-based compensation and accounted for as a share-based liability award. As at May 31, 2020, the liability recorded in association with this award is approximately $2 million (February 29, 2020 - $1 million). As at May 31, 2020, the Company has received $12 million in funds from claims filed with the Ministry of Innovation, Science and Economic Development Canada relating to its Strategic Innovation Fund program’s investment in BlackBerry QNX. A portion of this amount may be repayable in the future under certain circumstances if certain terms and conditions are not met by the Company, which is not probable at this time. (c) Concentrations in Certain Areas of the Company’s Business The Company attempts to ensure that most components essential to the Company’s business are generally available from multiple sources; however, certain components are currently obtained from limited sources within a competitive market, which subjects the Company to supply, availability and pricing risks. The Company has also entered into various agreements for the supply of components, and the manufacturing of its products; however, there can be no guarantee that the Company will be able to extend or renew these agreements on similar terms, or at all. Therefore, the Company remains subject to risks of supply shortages. (d) Indemnifications The Company enters into certain agreements that contain indemnification provisions under which the Company could be subject to costs and damages, including in the event of an infringement claim against the Company or an indemnified third party. Such intellectual property infringement indemnification clauses are generally not subject to any dollar limits and remain in effect for the term of the Company’s agreements. To date, the Company has not encountered material costs as a result of such indemnifications. The Company has entered into indemnification agreements with its current and former directors and executive officers. Under these agreements, the Company agreed, subject to applicable law, to indemnify its current and former directors and executive officers against all costs, charges and expenses reasonably incurred by such individuals in respect of any civil, criminal or administrative action that could arise by reason of their status as directors or officers. The Company maintains liability insurance coverage for the benefit of the Company, and its current and former directors and executive officers. The Company has not encountered material costs as a result of such indemnifications in the current period. See the Company’s Management Information Circular for fiscal 2020 for additional information regarding the Company’s indemnification agreements with its current and former directors and executive officers.

Revenue and Segment Disclosures

Revenue and Segment Disclosures	3 Months Ended
	May 31, 2020
Segment Reporting [Abstract]
Revenue and Segment Disclosures	REVENUE AND SEGMENT DISCLOSURES Revenue The Company disaggregates revenue from contracts with customers based on geographical regions, timing of revenue recognition, and the major product and service types. The Company’s revenue, classified by major geographic region in which the Company’s customers are located, was as follows: Three Months Ended May 31, 2020 May 31, 2019 North America (1) $ 150 $ 160 Europe, Middle East and Africa 41 61 Other regions 15 26 Total $ 206 $ 247 North America (1) 72.8 % 64.8 % Europe, Middle East and Africa 19.9 % 24.7 % Other regions 7.3 % 10.5 % Total 100.0 % 100.0 % ______________________________ (1) North America includes all revenue from the Company’s intellectual property arrangements, due to the global applicability of the patent portfolio and licensing arrangements thereof. Total revenue, classified by product and service type, was as follows: Three Months Ended May 31, 2020 May 31, 2019 Software and Services $ 148 $ 168 Licensing and Other 58 79 Total $ 206 $ 247 Software and Services includes revenue from the Company’s BlackBerry Spark software platform and BlackBerry IoT Solutions. The BlackBerry Spark platform includes a suite of security software products and services, including BlackBerry Cylance, BlackBerry UEM, BlackBerry Dynamics and BlackBerry Workspaces. BlackBerry IoT Solutions includes revenue from BlackBerry QNX, BlackBerry AtHoc, SecuSUITE, BlackBerry Certicom, BlackBerry Radar, and other IoT applications. Software and Services revenue is generated predominantly through software licenses, commonly bundled with support, maintenance and professional services. Licensing and Other includes revenue from the Company’s intellectual property licensing arrangements, BBM Consumer licensing arrangement, settlement awards and mobility licensing software arrangements, which includes revenue from licensed hardware sales. Other includes revenue associated with the Company’s legacy service access fees (“SAF”) business, as well as revenue relating to unspecified future software upgrade rights for devices previously sold by the Company. Revenue, classified by timing of recognition, was as follows: Three Months Ended May 31, 2020 May 31, 2019 Products and services transferred over time $ 116 $ 152 Products and services transferred at a point in time 90 95 Total $ 206 $ 247 Revenue contract balances The following table sets forth the activity in the Company’s revenue contract balances for the three months ended May 31, 2020: Accounts Receivable Deferred Revenue Deferred Commissions Opening balance as at February 29, 2020 $ 267 $ 373 $ 28 Increases due to invoicing of new or existing contracts, associated contract acquisition costs, or other 181 117 8 Decrease due to payment, fulfillment of performance obligations, or other (193) (149) (9) Decrease, net (12) (32) (1) Closing balance as at May 31, 2020 $ 255 $ 341 $ 27 Transaction price allocated to the remaining performance obligations The table below discloses the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied as at May 31, 2020 and the time frame in which the Company expects to recognize this revenue. The disclosure includes estimates of variable consideration, except when the variable consideration is a sales-based or usage-based royalty promised in exchange for a license of intellectual property. As at May 31, 2020 Less than 12 Months 12 to 24 Months Thereafter Total Remaining performance obligations $ 264 $ 90 $ 32 $ 386 Revenue recognized for performance obligations satisfied in prior periods For the three months ended May 31, 2020, no revenue was recognized relating to performance obligations satisfied in a prior period (three months ended May 31, 2019 - nil). Segment Disclosures The Company reports segment information based on the “management” approach. The management approach designates the internal reporting used by the Chief Operating Decision Maker (“CODM”) for making decisions and assessing performance as a source of the Company’s reportable operating segments. The CODM, who is the Executive Chair and CEO, reviews financial information, makes decisions and assesses the performance of the Company as a single operating segment. Property, plant and equipment, intangible assets, operating lease ROU assets and goodwill, classified by geographic region in which the Company’s assets are located, were as follows: As at May 31, 2020 February 29, 2020 Property, Plant and Equipment, Intangible Assets, Operating Lease ROU Assets and Goodwill Total Assets Property, Plant and Equipment, Intangible Assets, Operating Lease ROU Assets and Goodwill Total Assets Canada $ 356 $ 706 $ 374 $ 657 United States 1,511 2,360 2,132 3,071 Other 38 149 40 160 $ 1,905 $ 3,215 $ 2,546 $ 3,888 Information About Major Customers There was one customer that comprised 26% of the Company’s revenue in three months ended May 31, 2020 (three months ended May 31, 2019 - one customer that comprised 16% of the Company’s revenue).

Cash Flow and Additional Inform

Cash Flow and Additional Information	3 Months Ended
	May 31, 2020
Supplemental Cash Flow Information [Abstract]
Cash Flow and Additional Information	CASH FLOW AND ADDITIONAL INFORMATION (a) Certain consolidated statements of cash flow information related to interest and income taxes paid is summarized as follows: For the Three Months Ended May 31, 2020 May 31, 2019 Interest paid during the period $ 6 $ 6 Income taxes paid during the period — 1 Income tax refunds received during the period 1 2 (b) Additional Information Foreign exchange The Company is exposed to foreign exchange risk as a result of transactions in currencies other than its functional currency, the U.S. dollar. The majority of the Company’s revenue in the first quarter of fiscal 2021 was transacted in U.S. dollars. Portions of the revenue were denominated in Canadian dollars, euros and British pounds. Other expenses, consisting mainly of salaries and certain other operating costs, were incurred primarily in Canadian dollars, but were also incurred in U.S. dollars, euros and British pounds. At May 31, 2020, approximately 12% of cash and cash equivalents, 11% of accounts receivable and 32% of accounts payable were denominated in foreign currencies (February 29, 2020 – 12%, 17% and 17%, respectively). These foreign currencies primarily include the Canadian dollar, euro and British pound. As part of its risk management strategy, the Company maintains net monetary asset and/or liability balances in foreign currencies and engages in foreign currency hedging activities using derivative financial instruments, including currency forward contracts and currency options. The Company does not use derivative instruments for speculative purposes. Interest rate risk Cash and cash equivalents and investments are invested in certain instruments of varying maturities. Consequently, the Company is exposed to interest rate risk as a result of holding investments of varying maturities. The fair value of investments, as well as the investment income derived from the investment portfolio, will fluctuate with changes in prevailing interest rates. The Company has also issued the Debentures as described in Note 6 with a fixed 3.75% interest rate. The fair value of the Debentures will fluctuate with changes in prevailing interest rates. Consequently, the Company is exposed to interest rate risk as a result of the Debentures. The Company does not currently utilize interest rate derivative instruments to hedge its investment portfolio. Credit risk The Company is exposed to market and credit risk on its investment portfolio. The Company reduces this risk by investing in liquid, investment-grade securities and by limiting exposure to any one entity or group of related entities. As at May 31, 2020, no single issuer represented more than 12% of the total cash, cash equivalents and investments (February 29, 2020 - no single issuer represented more than 8% of the total cash, cash equivalents and investments), representing cash balances at one of the Company’s banking counterparties. The Company maintains Credit Support Annexes (“CSAs”) with several of its counterparties. These CSAs require the outstanding net position of all contracts be made whole by the paying or receiving of collateral to or from the counterparties on a daily basis, subject to exposure and transfer thresholds. As at May 31, 2020, the Company had $2 million in collateral held with counterparties (February 29, 2020 - $1 million in collateral posted). Liquidity risk Cash, cash equivalents, and investments were approximately $955 million as at May 31, 2020. The Company’s management remains focused on efficiently managing working capital balances and managing the liquidity needs of the business. Based on its current financial projections, the Company believes its financial resources, together with expected future operating cash generating and operating expense reduction activities and access to other potential financing arrangements, should be sufficient to meet funding requirements for current financial commitments and future operating expenditures not yet committed, and should provide the necessary financial capacity for the foreseeable future. Government subsidies During the first quarter of fiscal 2021, the Government of Canada announced the Canada Emergency Wage Subsidy (“CEWS”) for Canadian employers whose businesses were affected by the COVID-19 pandemic. The CEWS provides a subsidy of up to 75% of eligible employees’ employment insurable remuneration, subject to certain criteria. Accordingly, the Company applied for the CEWS to the extent it met the requirements to receive the subsidy and during the three months ended May 31, 2020, recorded $9 million in government subsidies as a reduction to operating expenses in the consolidated statement of operations.

Blackberry Limited and Summar_2

Blackberry Limited and Summary of Significant Accounting Policies and Critical Accounting Estimates (Policies)	3 Months Ended
	May 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of presentation and preparation	Basis of Presentation and Preparation These interim consolidated financial statements have been prepared by management in accordance with United States generally accepted accounting principles (“U.S. GAAP”). They do not include all of the disclosures required by U.S. GAAP for annual financial statements and should be read in conjunction with the audited consolidated financial statements of BlackBerry Limited (the “Company”) for the year ended February 29, 2020 (the “Annual Financial Statements”), which have been prepared in accordance with U.S. GAAP. In the opinion of management, all normal recurring adjustments considered necessary for fair presentation have been included in these interim consolidated financial statements. Operating results for the three months ended May 31, 2020 are not necessarily indicative of the results that may be expected for the full year ending February 28, 2021. The consolidated balance sheet at February 29, 2020 was derived from the audited Annual Financial Statements but does not contain all of the footnote disclosures from the Annual Financial Statements. Certain of the comparative figures have been reclassified to conform to the current period’s presentation. The Company operates as a single reportable segment. For additional information concerning the Company’s segment reporting, see Note 11.
New Accounting Pronouncements	Accounting Standards Adopted During Fiscal 2021 ASC 350, Goodwill and Other In January 2017, the Financial Accounting Standards Board (“FASB”) released ASU 2017-04 on the topic of Intangibles— Goodwill and Other (ASC 350). ASU 2017-04 simplifies the subsequent measurement of goodwill, eliminating Step 2 from the goodwill impairment test. Previously, under Step 2, an entity had to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities (including unrecognized assets and liabilities) following the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination. Instead, under the amendments of ASU 2017-04, an entity performs its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. The Company will recognize an impairment charge for any amount by which the carrying amount exceeds the reporting unit’s fair value. The amendments in this update were effective for an entity’s annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. The Company adopted this standard on March 1, 2020. ASC 326, Credit Losses In June 2016, the FASB released ASU 2016-13 on the topic of Financial Instruments — Credit Losses (ASC 326). ASU 2016-13 replaces the previous incurred loss impairment methodology in U.S. GAAP with a methodology that reflects expected credit losses, requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates, and requires entities to estimate an expected lifetime credit loss on its financial assets. The guidance also amends the impairment model for available-for-sale debt securities, requiring entities to determine whether all or a portion of the unrealized loss on such securities is a credit loss, and also eliminating the option for management to consider the length of time a security has been in an unrealized loss position as a factor in concluding whether or not a credit loss exists. The amended model states that an entity recognizes an allowance for credit losses on available-for-sale debt securities, instead of a direct reduction of the amortized cost basis of the investment, as required under previous guidance. As a result, entities recognize improvements to estimated credit losses on available-for-sale debt securities immediately in earnings as opposed to in interest income over time. The guidance was effective for interim and annual periods beginning after December 15, 2019. The Company adopted this guidance in the first quarter of fiscal 2021 using the modified retrospective method. As a result of the adoption of the new standard on credit losses, the Company recorded a cumulative adjustment to the consolidated balance sheet increasing the allowance for credit losses and increasing deficit by approximately $4 million as at March 1, 2020. As a result, the allowance for credit losses was $13 million in the consolidated balance sheet as at March 1, 2020.
Goodwill	Goodwill Goodwill represents the excess of the acquisition price in a business combination over the fair value of identifiable net assets acquired. Goodwill is allocated at the date of the business combination. Goodwill is not amortized but is tested for impairment annually on December 31 or more frequently if events or changes in circumstances indicate the asset may be impaired. These events and circumstances may include a significant change in legal factors or in the business climate, a significant decline in the Company’s share price, an adverse action or assessment by a regulator, unanticipated competition, a loss of key personnel, significant disposal activity and the testing of recoverability for a significant asset group. The Company’s impairment test is carried out in one step. The carrying amount of the reporting unit, including goodwill, was compared with its fair value. The estimated fair value was determined utilizing multiple approaches based on the nature of the reporting units being valued. In its analysis, the Company utilized multiple valuation techniques, including the income approach, discounted future cash flows, the market-based approach, and the asset value approach. The analysis requires significant judgment, including estimation of future cash flows, which is dependent on internal forecasts, estimation of the long-term rate of revenue growth for our reporting units, estimation of the useful life over which cash flows will occur, terminal growth rate, profitability measures, and determination of the discount rates for the reporting units. The carrying amount of the Company’s assets was assigned to reporting units using reasonable methodologies based on the asset type. When the carrying amount of a reporting unit exceeds its fair value, goodwill of the reporting unit is considered to be impaired and written down to its fair value. Different judgments could yield different results. Events and circumstances resulted in a goodwill impairment test being conducted as at May 31, 2020; see Note 4.
Accounts Receivable	Accounts receivable, net The accounts receivable balance reflects invoiced and accrued revenue and is presented net of an allowance for credit losses. The Company expects the majority of its accounts receivable balances to continue to come from large customers as it sells the majority of its software products and services through resellers and network carriers rather than directly. The Company establishes current expected credit losses (“CECL”) for pools of assets with similar risk characteristics by evaluating historical levels of credit losses, current economic conditions that may affect a customer’s ability to pay, and creditworthiness of significant customers. When specific customers are identified as no longer sharing the same risk profile as their current pool, they are removed from the pool and evaluated separately. The Company, in the normal course of business, monitors the financial condition of its customers and reviews the credit history of each new customer. When
Investment, Policy	Investments The Company’s cash equivalents and investments, other than publicly issued equity securities and private equity investments without readily determinable fair value, consist of money market and other debt securities, which are classified as available-for-sale for accounting purposes and are carried at fair value. Unrealized gains and losses, net of related income taxes, are recorded in Accumulated Other Comprehensive Loss (“AOCL”) until such investments mature or are sold. The Company uses the specific identification method of determining the cost basis in computing realized gains or losses on available-for-sale investments, which are recorded in investment income. The Company does not exercise significant influence with respect to any of these investments. Publicly issued equity securities are recorded at fair value and revalued at each reporting period with changes in fair value recorded through investment income. The Company elects to record private equity investments without readily determinable fair value at cost minus impairment, as adjusted for any changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer. The Company reassesses each reporting period that its private equity investments without readily determinable fair value continue to qualify for this treatment. Investments with maturities at the time of purchase of three months or less are classified as cash equivalents. Investments with maturities of one year or less (but which are not cash equivalents), public equity investments and any investments that the Company intends to hold for less than one year are classified as short-term investments. Investments with maturities in excess of one year or investments that the Company does not intend to sell are classified as long-term investments.
Credit Loss, Financial Instrument	Allowance for Credit Losses on Available-for-sales Debt Securities The Company accounts for credit losses on available-for-sale debt securities in accordance with ASC 326. The Company adopted ASC 326 on March 1, 2020, on a modified retrospective basis. Under ASC 326, at each reporting period, the Company evaluates its available-for-sale debt securities at the individual security level to determine whether there is a decline in the fair value below its amortized cost basis (an impairment). In circumstances where the Company intends to sell, or is more likely than not required to sell, the security before it recovers its amortized cost basis, the difference between fair value and amortized cost is recognized as a loss in the consolidated statement of operations, with a corresponding write-down of the security’s amortized cost. In circumstances where neither condition exists, the Company then evaluates whether a decline is due to credit-related factors. The factors considered in determining whether a credit loss exists can include the extent to which fair value is less than the amortized cost basis, changes in the credit quality of the underlying issuer, credit ratings actions, as well as other factors. To determine the portion of a decline in fair value that is credit-related, the Company compares the present value of the expected cash flows of the security discounted at the security’s effective interest rate to the amortized cost basis of the security. A credit-related impairment is limited to the difference between fair value and amortized cost, and recognized as an allowance for credit loss on the consolidated balance sheet with a corresponding adjustment to net income. Any remaining decline in fair value that is non-credit related is recognized in other comprehensive income (loss), net of tax. Improvements in expected cash flows due to improvements in credit are recognized through reversal of the credit loss and corresponding reduction in the allowance for credit loss.
Government Subsidies	Government Subsidies The Company recognizes government subsidies as a reduction to operating expenses in the consolidated statement of operations when there is reasonable assurance the Company will receive the amount and has complied with the conditions, if any, attached to the government subsidies.

Fair Value Measurements, Cash_2

Fair Value Measurements, Cash, Cash Equivalent and Investments (Tables)	3 Months Ended
	May 31, 2020
Cash and Cash Equivalents [Abstract]
Components of Cash, Cash Equivalents and Investments	The components of cash, cash equivalents and investments by fair value level as at May 31, 2020 were as follows: Cost Basis Unrealized Unrealized Other-than- Fair Value Cash and Short-term Long-term Restricted Cash Bank balances $ 120 $ — $ — $ — $ 120 $ 120 $ — $ — $ — Other investments 33 — — — 33 — — 33 — 153 — — — 153 120 — 33 — Level 1: Equity securities 10 — (8) — 2 — 2 — — Level 2: Corporate notes/bonds 37 — — — 37 37 — — — Term deposits, certificates of deposits, and GICs 108 — — — 108 10 50 — 48 Bearer deposit notes 131 — — — 131 79 52 — — Commercial paper 289 — — — 289 62 227 — — Non-U.S. promissory notes 172 — — — 172 4 168 — — Non-U.S. government sponsored enterprise notes 38 — — — 38 — 38 — — Non-U.S. treasury bills/notes 25 — — — 25 — 25 — — 800 — — — 800 192 560 — 48 $ 963 $ — $ (8) $ — $ 955 $ 312 $ 562 $ 33 $ 48 The components of cash, cash equivalents and investments by fair value level as at February 29, 2020 were as follows: Cost Basis Unrealized Unrealized Other-than- Fair Value Cash and Short-term Long-term Restricted Cash and Cash Equivalents Bank balances $ 100 $ — $ — $ — $ 100 $ 100 $ — $ — $ — Other investments 32 — — — 32 — — 32 — 132 — — — 132 100 — 32 — Level 1: Equity securities 10 — (8) — 2 — 2 — — Level 2: Term deposits, certificates of deposits, and GICs 118 — — — 118 44 25 — 49 Bankers’ acceptances/bearer deposit notes 84 — — — 84 30 54 — — Commercial paper 276 — — — 276 108 168 — — Non-U.S. promissory notes 133 — — — 133 25 108 — — Non-U.S. government sponsored enterprise notes 144 — — — 144 — 144 — — Non-U.S. treasury bills/notes 56 — — — 56 25 31 — — U.S. treasury bills/notes 45 — — — 45 45 — — — 856 — — — 856 277 530 — 49 $ 998 $ — $ (8) $ — $ 990 $ 377 $ 532 $ 32 $ 49
Schedule of Cash and Cash Equivalents	The following table provides a reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents as at May 31, 2020 and February 29, 2020 from the consolidated balance sheets to the consolidated statements of cash flows: As at May 31, 2020 February 29, 2020 Cash and cash equivalents $ 312 $ 377 Restricted cash and cash equivalents 48 49 Total cash, cash equivalents, restricted cash, and restricted cash equivalents presented in the consolidated statements of cash flows $ 360 $ 426
Contractual Maturities of Available-for-Sale Investments	The contractual maturities of available-for-sale investments as at May 31, 2020 and February 29, 2020 were as follows: As at May 31, 2020 February 29, 2020 Cost Basis Fair Value Cost Basis Fair Value Due in one year or less $ 800 $ 800 $ 856 $ 856 No fixed maturity 10 2 10 2 $ 810 $ 802 $ 866 $ 858

Consolidated Balance Sheets D_2

Consolidated Balance Sheets Details (Tables)	3 Months Ended
	May 31, 2020
Balance Sheet Related Disclosures [Abstract]
Accounts Receivable, Allowance for Credit Loss	The following table sets forth the activity in the Company’s allowance for credit losses: Three Months Ended May 31, 2020 Beginning balance as of February 29, 2020 $ 9 Impact of adopting ASC 326 4 Current period provision for expected credit losses — Ending balance of the allowance for credit loss as at May 31, 2020 $ 13 The allowance for credit losses as at May 31, 2020 consists of $6 million relating to CECL estimated based on days past due and region, $6 million relating to specific customers that were evaluated separately and $1 million relating to CECL estimated for long-term accounts receivables.
Property, Plant and Equipment	Property, plant and equipment comprised the following: As at May 31, 2020 February 29, 2020 Cost Buildings, leasehold improvements and other $ 72 $ 72 BlackBerry operations and other information technology 82 84 Manufacturing, repair and research and development equipment 73 73 Furniture and fixtures 11 11 238 240 Accumulated amortization 172 170 Net book value $ 66 $ 70
Intangible Assets	Intangible assets comprised the following: As at May 31, 2020 Cost Accumulated Net Book Acquired technology $ 1,020 $ 656 $ 364 Intellectual property 493 284 209 Other acquired intangibles 494 189 305 $ 2,007 $ 1,129 $ 878 As at February 29, 2020 Cost Accumulated Net Book Acquired technology $ 1,019 $ 636 $ 383 Intellectual property 489 275 214 Other acquired intangibles 494 176 318 $ 2,002 $ 1,087 $ 915
Changes to Carrying Amount of Goodwill	Changes to the carrying amount of goodwill during the three months ended May 31, 2020 were as follows: Carrying Amount Carrying amount as at February 29, 2020 1,437 Goodwill impairment charge (594) Carrying amount as at May 31, 2020 $ 843

Debentures (Tables)

Debentures (Tables)	3 Months Ended
	May 31, 2020
Debt Disclosure [Abstract]
Schedule of Debentures	The following table summarizes the change in fair value of the Debentures for the three months ended May 31, 2020: As at May 31, 2020 Balance as at February 29, 2020 606 Change in fair value of the Debentures (7) Balance as at May 31, 2020 $ 599 The following table shows the impact of the changes in fair value of the Debentures for the three months ended May 31, 2020 and May 31, 2019: Three Months Ended May 31, 2020 May 31, 2019 Income (charge) associated with the change in fair value from non-credit components recorded in the consolidated statements of operations $ (1) $ 28 Income (charge) associated with the change in fair value from instrument-specific credit components recorded in AOCL 8 (8) Total decrease (increase) in the fair value of the Debentures $ 7 $ 20

Capital Stock (Tables)

Capital Stock (Tables)	3 Months Ended
	May 31, 2020
Share-based Payment Arrangement, Noncash Expense [Abstract]
Changes in Issued and Outstanding Common Shares	The following details the changes in issued and outstanding common shares for the three months ended May 31, 2020: Capital Stock and Stock Amount Common shares outstanding as at February 29, 2020 554,199 2,760 Exercise of stock options 300 1 Common shares issued for restricted share unit settlements 325 — Stock-based compensation — 13 Common shares issued for employee share purchase plan 799 3 Common shares outstanding as at May 31, 2020 555,623 $ 2,777

Earnings (Loss) Per Share (Tabl

Earnings (Loss) Per Share (Tables)	3 Months Ended
	May 31, 2020
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Earnings Per Share	The following table sets forth the computation of basic and diluted loss per share: Three Months Ended May 31, 2020 May 31, 2019 Net loss for basic and diluted loss per share available to common shareholders $ (636) $ (35) Less: Debentures fair value adjustment (1) (2) — (28) Add: interest expense on Debentures (1) (2) — 6 Net loss for diluted loss per share available to common shareholders $ (636) $ (57) Weighted average number of shares outstanding (000’s) - basic (3) (4) 557,839 551,845 Effect of dilutive securities (000’s) Conversion of Debentures (1) (2) — 60,500 Weighted average number of shares and assumed conversions (000’s) diluted 557,839 612,345 Loss per share - reported Basic $ (1.14) $ (0.06) Diluted $ (1.14) $ (0.09) ______________________________ (1) The Company has not presented the dilutive effect of the Debentures using the if-converted method in the calculation of diluted loss per share for the three months ended May 31, 2020, as to do so would be antidilutive. See Note 6 for details on the Debentures. (2) The Company has presented the dilutive effect of the Debentures using the if-converted method, assuming conversion at the beginning of the quarter for the three months ended May 31, 2019. Accordingly, to calculate diluted loss per share, the Company adjusted net loss by eliminating the fair value adjustment made to the Debentures and interest expense incurred on the Debentures in the three months ended May 31, 2019, and added the number of shares that would have been issued upon conversion to the diluted weighted average number of shares outstanding. See Note 6 for details on the Debentures. (3) For the three months ended May 31, 2020, includes approximately 2,802,067 common shares remaining to be issued in equal installments on the next two anniversary dates of the Cylance acquisition, in consideration for the acquisition. For the three months ended May 31, 2019, includes approximately 4,182,189 common shares to be issued in equal installments on the three anniversary dates of the Cylance acquisition, in consideration for the acquisition. There are no service or other requirements associated with the issuance of these shares. (4) The Company has not presented the dilutive effect of in-the-money options and RSUs that will be settled upon vesting by the issuance of new common shares in the calculation of diluted loss per share for the three months ended May 31, 2020, and three months ended May 31, 2019, as to do so would be antidilutive.

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	3 Months Ended
	May 31, 2020
Equity [Abstract]
Components of Accumulated Other Comprehensive Loss	The changes in AOCL by component net of tax, for the three months ended May 31, 2020 were as follows: Foreign Currency Cumulative Translation Adjustment Accumulated Net Unrealized Losses on Cash Flow Hedges Other Post-Employment Benefit Obligations Change in fair value from instrument-specific credit risk on Debentures Total AOCL as at February 29, 2020 $ (9) $ (1) $ (1) $ (22) $ (33) Other comprehensive income before reclassification 1 $ 1 $ — 7 $ 9 Amounts reclassified from AOCL into net loss — (2) — — (2) Change in cumulative comprehensive income (loss) for the period 1 (1) — 7 7 AOCL as at May 31, 2020 $ (8) $ (2) $ (1) $ (15) $ (26)

Revenue and Segment Disclosure

Revenue and Segment Disclosure (Tables)	3 Months Ended
	May 31, 2020
Segment Reporting [Abstract]
Revenue from External Customers by Geographic Areas	The Company’s revenue, classified by major geographic region in which the Company’s customers are located, was as follows: Three Months Ended May 31, 2020 May 31, 2019 North America (1) $ 150 $ 160 Europe, Middle East and Africa 41 61 Other regions 15 26 Total $ 206 $ 247 North America (1) 72.8 % 64.8 % Europe, Middle East and Africa 19.9 % 24.7 % Other regions 7.3 % 10.5 % Total 100.0 % 100.0 % ______________________________ (1) North America includes all revenue from the Company’s intellectual property arrangements, due to the global applicability of the patent portfolio and licensing arrangements thereof.
Revenue by Product and Service Type	Total revenue, classified by product and service type, was as follows: Three Months Ended May 31, 2020 May 31, 2019 Software and Services $ 148 $ 168 Licensing and Other 58 79 Total $ 206 $ 247
Revenue Classified by Timing of Recognition	Revenue, classified by timing of recognition, was as follows: Three Months Ended May 31, 2020 May 31, 2019 Products and services transferred over time $ 116 $ 152 Products and services transferred at a point in time 90 95 Total $ 206 $ 247
Revenue Contract Balances	The following table sets forth the activity in the Company’s revenue contract balances for the three months ended May 31, 2020: Accounts Receivable Deferred Revenue Deferred Commissions Opening balance as at February 29, 2020 $ 267 $ 373 $ 28 Increases due to invoicing of new or existing contracts, associated contract acquisition costs, or other 181 117 8 Decrease due to payment, fulfillment of performance obligations, or other (193) (149) (9) Decrease, net (12) (32) (1) Closing balance as at May 31, 2020 $ 255 $ 341 $ 27
Transaction Price Allocated to the Remaining Performance Obligation	The table below discloses the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied as at May 31, 2020 and the time frame in which the Company expects to recognize this revenue. The disclosure includes estimates of variable consideration, except when the variable consideration is a sales-based or usage-based royalty promised in exchange for a license of intellectual property. As at May 31, 2020 Less than 12 Months 12 to 24 Months Thereafter Total Remaining performance obligations $ 264 $ 90 $ 32 $ 386
Long-lived Assets and Total Assets by Geographic Areas	Property, plant and equipment, intangible assets, operating lease ROU assets and goodwill, classified by geographic region in which the Company’s assets are located, were as follows: As at May 31, 2020 February 29, 2020 Property, Plant and Equipment, Intangible Assets, Operating Lease ROU Assets and Goodwill Total Assets Property, Plant and Equipment, Intangible Assets, Operating Lease ROU Assets and Goodwill Total Assets Canada $ 356 $ 706 $ 374 $ 657 United States 1,511 2,360 2,132 3,071 Other 38 149 40 160 $ 1,905 $ 3,215 $ 2,546 $ 3,888

Cash Flow and Additional Info_2

Cash Flow and Additional Information (Tables)	3 Months Ended
	May 31, 2020
Supplemental Cash Flow Information [Abstract]
Supplemental Cash Flow Information	(a) Certain consolidated statements of cash flow information related to interest and income taxes paid is summarized as follows: For the Three Months Ended May 31, 2020 May 31, 2019 Interest paid during the period $ 6 $ 6 Income taxes paid during the period — 1 Income tax refunds received during the period 1 2

Blackberry Limited and Summar_3

Blackberry Limited and Summary of Significant Accounting Policies and Critical Accounting Estimates - Adoption of Accounting Policies (Details) - USD ($) $ in Millions	May 31, 2020	Mar. 01, 2020	Feb. 29, 2020	May 31, 2019	Feb. 28, 2019
New Accounting Pronouncement, Early Adoption [Line Items]
Stockholders' Equity Attributable to Parent	$ (1,913)		$ (2,529)	$ (2,597)	$ (2,636)
Accounts Receivable, Allowance for Credit Loss	$ 13	$ 13	9
Cumulative Effect, Period of Adoption, Adjustment | Accounting Standards Update 2016-13
New Accounting Pronouncement, Early Adoption [Line Items]
Stockholders' Equity Attributable to Parent			$ 4

Cash, Cash Equivalents and Inve

Cash, Cash Equivalents and Investments - Components of Cash, Cash Equivalents and Investments (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	May 31, 2020	Feb. 29, 2020
Cash and Cash Equivalents [Line Items]
Cost Basis	$ 963	$ 998
Unrealized Gains	0	0
Unrealized Losses	8	(8)
Other-than- temporary Impairment	0	0
Fair Value	955	990
Cash and Cash Equivalents	312	377
Short-term Investments	562	532
Long-term investments (note 3)	33	32
Restricted cash and cash equivalents	48	49
Bank balances
Cash and Cash Equivalents [Line Items]
Cost Basis	120	100
Unrealized Gains	0	0
Unrealized Losses	0	0
Other-than- temporary Impairment	0	0
Fair Value	120	100
Cash and Cash Equivalents	120	100
Short-term Investments	0	0
Long-term investments (note 3)	0	0
Restricted cash and cash equivalents (note 3)	0	0
Other investments
Cash and Cash Equivalents [Line Items]
Cost Basis	33	32
Unrealized Gains	0	0
Unrealized Losses	0	0
Other-than- temporary Impairment	0	0
Fair Value	33	32
Cash and Cash Equivalents	0	0
Short-term Investments	0	0
Long-term investments (note 3)	33	32
Restricted cash and cash equivalents (note 3)	0	0
Bank Balances and Other Investments [Domain]
Cash and Cash Equivalents [Line Items]
Cost Basis	153	132
Unrealized Gains	0	0
Unrealized Losses	0	0
Other-than- temporary Impairment	0	0
Fair Value	153	132
Cash and Cash Equivalents	120	100
Short-term Investments	0	0
Long-term investments (note 3)	33	32
Restricted cash and cash equivalents (note 3)	0	0
Level 1: | Equity securities
Cash and Cash Equivalents [Line Items]
Cost Basis	10	10
Unrealized Gains	0	0
Unrealized Losses	(8)	(8)
Other-than- temporary Impairment	0	0
Fair Value	2	2
Cash and Cash Equivalents	0	0
Short-term Investments	2	2
Long-term investments (note 3)	0	0
Restricted cash and cash equivalents (note 3)	0	0
Level 2:
Cash and Cash Equivalents [Line Items]
Cost Basis	800	856
Unrealized Gains	0	0
Unrealized Losses	0	0
Other-than- temporary Impairment	0	0
Fair Value	800	856
Cash and Cash Equivalents	192	277
Short-term Investments	560	530
Long-term investments (note 3)	0	0
Restricted cash and cash equivalents (note 3)	48	49
Level 2: | Corporate notes/bonds
Cash and Cash Equivalents [Line Items]
Cost Basis	37
Unrealized Gains	0
Unrealized Losses	0
Other-than- temporary Impairment	0
Fair Value	37
Cash and Cash Equivalents	37
Short-term Investments	0
Long-term investments (note 3)	0
Restricted cash and cash equivalents (note 3)	0
Level 2: | Term deposits, certificates of deposits, and GICs
Cash and Cash Equivalents [Line Items]
Cost Basis	108	118
Unrealized Gains	0	0
Unrealized Losses	0	0
Other-than- temporary Impairment	0	0
Fair Value	108	118
Cash and Cash Equivalents	10	44
Short-term Investments	50	25
Long-term investments (note 3)	0	0
Restricted cash and cash equivalents (note 3)	48	49
Level 2: | Bearer deposit notes
Cash and Cash Equivalents [Line Items]
Cost Basis	131	84
Unrealized Gains	0	0
Unrealized Losses	0	0
Other-than- temporary Impairment	0	0
Fair Value	131	84
Cash and Cash Equivalents	79	30
Short-term Investments	52	54
Long-term investments (note 3)	0	0
Restricted cash and cash equivalents (note 3)	0	0
Level 2: | Commercial paper
Cash and Cash Equivalents [Line Items]
Cost Basis	289	276
Unrealized Gains	0	0
Unrealized Losses	0	0
Other-than- temporary Impairment	0	0
Fair Value	289	276
Cash and Cash Equivalents	62	108
Short-term Investments	227	168
Long-term investments (note 3)	0	0
Restricted cash and cash equivalents (note 3)	0	0
Level 2: | Non-U.S. promissory notes
Cash and Cash Equivalents [Line Items]
Cost Basis	172	133
Unrealized Gains	0	0
Unrealized Losses	0	0
Other-than- temporary Impairment	0	0
Fair Value	172	133
Cash and Cash Equivalents	4	25
Short-term Investments	168	108
Long-term investments (note 3)	0	0
Restricted cash and cash equivalents (note 3)	0	0
Level 2: | Non-U.S. government sponsored enterprise notes
Cash and Cash Equivalents [Line Items]
Cost Basis	38	144
Unrealized Gains	0	0
Unrealized Losses	0	0
Other-than- temporary Impairment	0	0
Fair Value	38	144
Cash and Cash Equivalents	0	0
Short-term Investments	38	144
Long-term investments (note 3)	0	0
Restricted cash and cash equivalents (note 3)	0	0
Level 2: | Non-U.S. treasury bills/notes
Cash and Cash Equivalents [Line Items]
Cost Basis	25	56
Unrealized Gains	0	0
Unrealized Losses	0	0
Other-than- temporary Impairment	0	0
Fair Value	25	56
Cash and Cash Equivalents	0	25
Short-term Investments	25	31
Long-term investments (note 3)	0	0
Restricted cash and cash equivalents (note 3)	$ 0	0
Level 2: | U.S. treasury bills/notes
Cash and Cash Equivalents [Line Items]
Cost Basis		45
Unrealized Gains		0
Unrealized Losses		0
Other-than- temporary Impairment		0
Fair Value		45
Cash and Cash Equivalents		45
Short-term Investments		0
Long-term investments (note 3)		0
Restricted cash and cash equivalents (note 3)		$ 0

Cash, Cash Equivalents and In_2

Cash, Cash Equivalents and Investments - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2020	May 31, 2019	Feb. 29, 2020
Cash and Cash Equivalents [Line Items]
Investments that are communicated to the third party for consideration of reasonableness, threshold limit for fair values	0.50%
Equity Investment without Readily Determinable Fair Value	$ 33		$ 32
Available-for-sale Securities, Gross Realized Losses	0	$ 0
Investments with continuous unrealized losses	$ 8	$ 10
Minimum
Cash and Cash Equivalents [Line Items]
Lease term	1 month
Maximum
Cash and Cash Equivalents [Line Items]
Lease term	5 years

Cash, Cash Equivalent, Restrict

Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent Presented in the Consolidated Statements of Cash Flow (Details) - USD ($) $ in Millions	May 31, 2020	Feb. 29, 2020	May 31, 2019	Feb. 28, 2019
Cash and Cash Equivalents [Abstract]
Cash and cash equivalents (note 3)	$ 312	$ 377
Restricted cash and cash equivalents	48	49
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total	$ 360	$ 426	$ 391	$ 582

Cash, Cash Equivalents and In_3

Cash, Cash Equivalents and Investments - Contractual Maturities of Available-for-Sale Investments (Details) - USD ($) $ in Millions	May 31, 2020	Feb. 29, 2020
Cost Basis
Due in one year or less	$ 800	$ 856
No fixed maturity	10	10
Total	810	866
Fair Value
Due in one year or less	800	856
No fixed maturity	2	2
Total	$ 802	$ 858

Consolidated Balance Sheets D_3

Consolidated Balance Sheets Details - Accounts Receivable (Details) $ in Millions	3 Months Ended
	May 31, 2020USD ($)	Feb. 29, 2020USD ($)	May 31, 2019USD ($)	Feb. 28, 2019USD ($)
Balance Sheet Related Disclosures [Abstract]
Accounts Receivable, Allowance for Credit Loss, Current		$ 9
Accounts Receivable, Allowance for Credit Loss, Relating to CECL Estimated Based on Days Past Due and Region	$ 6
Accounts Receivable, Allowance for Credit Loss, Relating to Customers Evaluated Separately	6
Accounts Receivable, Allowance for Credit Loss, Relating to CECL Estimated for Long-term Accounts Receivable	$ 1
Number of customers with a balance greater than 10% of total accounts receivable	2	2
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Accounts Receivable, Allowance for Credit Loss, Beginning Balance	$ 9
Current period provision for expected credit losses	0
Accounts Receivable, Allowance for Credit Loss, Ending Balance	13
Stockholders' Equity Attributable to Parent	$ (1,913)	$ (2,529)	$ (2,597)	$ (2,636)
Cumulative Effect, Period of Adoption, Adjustment | Accounting Standards Update 2016-13
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Stockholders' Equity Attributable to Parent		$ 4

Consolidated Balance Sheets D_4

Consolidated Balance Sheets Details - Other Current Assets (Details) $ in Millions	3 Months Ended
	May 31, 2020other_current_assetUSD ($)
Condensed Balance Sheet Statements, Captions [Line Items]
Other current assets greater than five percent of current assets | other_current_asset	0
Other Long-Term Assets Greater than Five Percent of Total Assets | $	0
Other Current Assets | Current assets
Condensed Balance Sheet Statements, Captions [Line Items]
Concentration risk, percentage	5.00%
Other Noncurrent Assets [Member] | Assets, Total
Condensed Balance Sheet Statements, Captions [Line Items]
Concentration risk, percentage	5.00%

Consolidated Balance Sheets D_5

Consolidated Balance Sheets Detail - Property, Plant and Equipment (Details) - USD ($) $ in Millions	May 31, 2020	Feb. 29, 2020
Property, Plant and Equipment [Line Items]
Cost of property, plant and equipment	$ 238	$ 240
Accumulated amortization	172	170
Net book value	66	70
Buildings, leasehold improvements and other
Property, Plant and Equipment [Line Items]
Cost of property, plant and equipment	72	72
BlackBerry operations and other information technology
Property, Plant and Equipment [Line Items]
Cost of property, plant and equipment	82	84
Manufacturing, repair and research and development equipment
Property, Plant and Equipment [Line Items]
Cost of property, plant and equipment	73	73
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Cost of property, plant and equipment	$ 11	$ 11

Consolidated Balance Sheets D_6

Consolidated Balance Sheets Detail - Intangible Assets (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2020	May 31, 2019	Feb. 29, 2020
Finite-Lived Intangible Assets [Line Items]
Cost	$ 2,007		$ 2,002
Accumulated Amortization	1,129		1,087
Net Book Value	878		915
Amortization expenses related to intangible assets	45	$ 47
Intangible assets acquired during the period	8	$ 7
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
2021	126
2022	145
2023	115
2024	107
2025	101
2026	95
Acquired technology
Finite-Lived Intangible Assets [Line Items]
Cost	1,020		1,019
Accumulated Amortization	656		636
Net Book Value	364		383
Intellectual property
Finite-Lived Intangible Assets [Line Items]
Cost	493		489
Accumulated Amortization	284		275
Net Book Value	209		214
Other acquired intangibles
Finite-Lived Intangible Assets [Line Items]
Cost	494		494
Accumulated Amortization	189		176
Net Book Value	$ 305		$ 318

Consolidated Balance Sheets D_7

Consolidated Balance Sheets Details Consolidated Balance Sheet Details - Changes to Carrying Amount of Goodwill (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2020	May 31, 2019
Goodwill [Roll Forward]
Carrying amount as of beginning of period	$ 1,437
Impairment of goodwill	594	$ 0
Carrying amount as of end of period	$ 843

Consolidated Balance Sheets D_8

Consolidated Balance Sheets Detail - Additional Information (Details) $ in Millions	3 Months Ended
	May 31, 2020USD ($)
Accrued Liabilities
Other accrued liabilities greater than five percent of current liabilities	0
Other Current Liabilities [Member] | Liabilities, Total
Accrued Liabilities
Concentration risk, percentage	5.00%

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2020	May 31, 2019	Feb. 29, 2020
Income Tax Disclosure [Abstract]
Effective Income Tax Rate Reconciliation, Percent	1.00%	(6.00%)
Unrecognized Tax Benefits	$ 61		$ 72
Unrecognized tax benefits netted against deferred income taxes	55
Unrecognized tax benefits included within taxes payable	$ 6

Debentures (Details)

Debentures (Details)	3 Months Ended
	May 31, 2020USD ($)shares$ / shares	May 31, 2019USD ($)shares	Feb. 29, 2020USD ($)$ / shares
Debt Instrument [Line Items]
Face amount of debt	$ 605,000,000		$ 605,000,000
Interest rate	3.75%		3.75%
Redemption period, end date	Nov. 13, 2020	Nov. 13, 2020
Par value of convertible debentures	$ 1,000
Convertible debt, number of shares upon conversion (in shares) | shares	100
Conversion of stock (in shares) | shares	60,500,000	60,500,000
Conversion price (in dollars per share) | $ / shares	$ 10		$ 10
Percent of debt holders (not less than)	25.00%
Interest rate in event of default	7.75%		7.75%
Percentage change of control	115.00%		115.00%
Ownership percentage by arms length party, common shares	35.00%		35.00%
Ownership percentage, common shares	50.00%		50.00%
Unpaid principal balance	$ 605,000,000
Fair Value, Option, Aggregate Differences, Long-term Debt Instruments	6,000,000
Periodic payment, interest	6,000,000
Debt Instrument, Periodic Payment, Interest - Q3 FY21	5,000,000
Related party principal amounts of 3.75% debenture owned	500,000,000
Selling Marketing And Administration Expenses
Debt Instrument [Line Items]
Interest expense, debt	$ 6,000,000	$ 6,000,000

Debentures - Change in Fair Val

Debentures - Change in Fair Value (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2020	May 31, 2019
Change in Fair Value of Debentures [Roll Forward]
Short-term Debt, Fair Value, beginning balance	$ 606
Debenture total fair value adjustment	7	$ 20
Short-term Debt, Fair Value, ending balance	$ 599

Debentures - Impact of Changes

Debentures - Impact of Changes in Fair Value of Debentures (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2020	May 31, 2019
Debt Disclosure [Abstract]
Fair Value, Option, Changes in Fair Value, Gain (Loss)	$ (1)	$ 28
Income (charge) associated with the change in fair value from instrument-specific credit components recorded in AOCL	8	(8)
Debenture total fair value adjustment	$ 7	$ 20

Capital Stock - Changes in Issu

Capital Stock - Changes in Issued and Outstanding Common Shares (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2020	May 31, 2019
Common Stock [Roll Forward]
Capital stock outstanding, Shares, Beginning Balance	554,199,016
Capital stock outstanding, Shares, Ending Balance	555,622,606
Common Stock, Amount [Roll Forward]
Exercise of stock options	$ 1	$ 1
Stock-based compensation	13	17
Employee share purchase plan	$ 3	2
Capital Stock and Additional Paid-in Capital
Common Stock [Roll Forward]
Capital stock outstanding, Shares, Beginning Balance	554,199,000
Exercise of stock options	300,000
Common shares issued for restricted share unit settlements	325,000
Common shares issued for employee share purchase plan	799,000
Capital stock outstanding, Shares, Ending Balance	555,623,000
Common Stock, Amount [Roll Forward]
Common Stock, Value, Outstanding	$ 2,760
Exercise of stock options	1	1
Stock-based compensation	13	17
Employee share purchase plan	3	$ 2
Common Stock, Value, Outstanding	$ 2,777

Capital Stock - Subsequent even

Capital Stock - Subsequent event (Details) - shares	3 Months Ended
	May 31, 2020	May 31, 2019	Jun. 22, 2020	Feb. 29, 2020
Equity [Abstract]
Common outstanding (in shares)	555,622,606			554,199,016
Class of Stock [Line Items]
Common outstanding (in shares)	555,622,606			554,199,016
Conversion of stock (in shares)	60,500,000	60,500,000
Voting Common Stock [Member] | Subsequent Event [Member]
Equity [Abstract]
Common outstanding (in shares)			556,000,000
Class of Stock [Line Items]
Common outstanding (in shares)			556,000,000
Employee Stock Option [Member] | Subsequent Event [Member]
Equity [Abstract]
Common outstanding (in shares)			5,000,000
Class of Stock [Line Items]
Common outstanding (in shares)			5,000,000
Restricted Share Units (RSUs) | Subsequent Event [Member]
Equity [Abstract]
Common outstanding (in shares)			24,000,000
Class of Stock [Line Items]
Common outstanding (in shares)			24,000,000
Deferred Share Unit | Subsequent Event [Member]
Equity [Abstract]
Common outstanding (in shares)			1,000,000
Class of Stock [Line Items]
Common outstanding (in shares)			1,000,000

Earnings (Loss) Per Share - Sum

Earnings (Loss) Per Share - Summary of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands	3 Months Ended
	May 31, 2020	May 31, 2019
Earnings Per Share [Abstract]
Net income (loss) for basic and diluted earnings (loss) per share available to common shareholders from continuing operations	$ (636,000,000)	$ (35,000,000)
Debentures fair value impact on EPS	0	(28,000,000)
Interest expense, debt adjustment impact on EPS	0	6,000,000
Net Income (Loss) Available to Common Stockholders, Diluted, Total	$ (636,000,000)	$ (57,000,000)
Weighted-average number of shares outstanding (000's) - basic and diluted (in shares)	557,839	551,845
Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities (in shares)	0	60,500
Weighted Average Number of Shares Outstanding, Diluted, Total (in shares)	557,839	612,345
Earnings (Loss) Per Share, Basic (in usd per share)	$ (1.14)	$ (0.06)
Earnings (Loss) Per Share, Diluted (in usd per share)	$ (1.14)	$ (0.09)
Exchange shares related to Cylance acquisition	$ 2,802,067	$ 4,182,189

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss - Components of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2020	May 31, 2019
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance	$ 2,529	$ 2,636
Other comprehensive income before reclassification	1
Change in cumulative comprehensive income (loss) for the period	7	(10)
Ending Balance	1,913	$ 2,597
Foreign Currency Cumulative Translation Adjustment
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance	(9)
Amounts reclassified from AOCL into net loss	0
Change in cumulative comprehensive income (loss) for the period	1
Ending Balance	(8)
Accumulated Net Unrealized Losses on Cash Flow Hedges
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance	(1)
Amounts reclassified from AOCL into net loss	(2)
Change in cumulative comprehensive income (loss) for the period	(1)
Ending Balance	(2)
Other Post-Employment Benefit Obligations
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance	(1)
Other comprehensive income before reclassification	0
Amounts reclassified from AOCL into net loss	0
Change in cumulative comprehensive income (loss) for the period	0
Ending Balance	(1)
Changes in fair value from instrument specific credit risk on Debentures
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance	(22)
Amounts reclassified from AOCL into net loss	0
Change in cumulative comprehensive income (loss) for the period	7
Ending Balance	(15)
AOCI Attributable to Parent
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance	(33)
Other comprehensive income before reclassification	9
Amounts reclassified from AOCL into net loss	(2)
Change in cumulative comprehensive income (loss) for the period	7
Ending Balance	$ (26)

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Loss - Location of Loss Reclassified from AOCI into Income (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2020	May 31, 2019
Selling, marketing and administration [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Gains (Losses) on Cash Flow Hedges	$ 2	$ (1)

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended
	May 31, 2020	Feb. 29, 2020
Loss Contingencies Line Items]
Collateral of outstanding letters of credit	$ 48
Executive Chair Grant Liability	2	$ 1
Funds from claim filed with Ministry of Innovation, Science and Economic Development Canada relating to Strategic Innovation Fund Program	12
Executive Chair and CEO [Member]
Loss Contingencies Line Items]
Contingent performance-based cash award	$ 90
10-day average closing price for cash award	$ 30
Expiry date of contingent performance-based cash award	Nov. 3, 2023

Revenue and Segment Disclosur_2

Revenue and Segment Disclosures - Revenue from External Customers by Geographic Areas (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2020	May 31, 2019
Segment Reporting [Abstract]
Number of customers that comprised more than 10% of total revenue	one	one
Segment Reporting Information [Line Items]
Total Revenue	$ 206	$ 247
Total Revenue Rate	100.00%	100.00%
Sales Revenue, Net [Member]
Segment Reporting Information [Line Items]
Concentration risk, percentage	26.00%	16.00%
North America
Segment Reporting Information [Line Items]
Total Revenue	$ 150	$ 160
Total Revenue Rate	72.80%	64.80%
EMEA
Segment Reporting Information [Line Items]
Total Revenue	$ 41	$ 61
Total Revenue Rate	19.90%	24.70%
Other Regions
Segment Reporting Information [Line Items]
Total Revenue	$ 15	$ 26
Total Revenue Rate	7.30%	10.50%

Revenue and Segment Disclosur_3

Revenue and Segment Disclosures - Revenue by Type (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2020	May 31, 2019
Revenue by Type [Line Items]
Revenues	$ 206	$ 247
Software and Services
Revenue by Type [Line Items]
Revenues	148	168
Licensing and Other
Revenue by Type [Line Items]
Revenues	$ 58	$ 79

Revenue and Segment Disclosur_4

Revenue and Segment Disclosures Revenue classified by timing of recognition (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2020	May 31, 2019
Revenue classified by timing of recognition [Line Items]
Revenues	$ 206	$ 247
Transferred over Time [Member]
Revenue classified by timing of recognition [Line Items]
Revenues	116	152
Transferred at Point in Time [Member]
Revenue classified by timing of recognition [Line Items]
Revenues	$ 90	$ 95

Revenue and Segment Disclosur_5

Revenue and Segment Disclosures Revenue Contract Balances (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2020	May 31, 2019
Revenue Contract Balances [Line Items]
Increase (Decrease) in Deferred Revenue	$ (32)	$ 27
Accounts Receivable
Revenue Contract Balances [Line Items]
Contract with Customer, Asset, Net - Current and Non-Current	267
Increase in contract receivable	181
Increase in contract receivable from business combination	(193)
Increase Decrease In Contract with Customer, Asset, Net - Current and Non-Current	(12)
Contract with Customer, Asset, Net - Current and Non-Current	255
Deferred Revenue
Revenue Contract Balances [Line Items]
Deferred Revenue	373
Deferred Revenue, Additions	117
Increase in deferred revenue from business combination	(149)
Increase (Decrease) in Deferred Revenue	(32)
Deferred Revenue	341
Deferred Commissions
Revenue Contract Balances [Line Items]
Capitalized Contract Cost, Net	28
Increase in deferred commission	8
Decrease in deferred commission	(9)
Net change in deferred commission	(1)
Capitalized Contract Cost, Net	$ 27

Revenue and Segment Disclosur_6

Revenue and Segment Disclosures -Transaction price allocated to the remaining performance obligations (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2020	May 31, 2019
Transaction price allocated to the remaining performance obligations [Line Items]
Revenue, Remaining Performance Obligation, Amount	$ 386
Contract with Customer, Performance Obligation Satisfied in Previous Period	0	$ 0
Less than 12 months
Transaction price allocated to the remaining performance obligations [Line Items]
Revenue, Remaining Performance Obligation, Amount	264
12 to 24 months
Transaction price allocated to the remaining performance obligations [Line Items]
Revenue, Remaining Performance Obligation, Amount	90
After 24 months
Transaction price allocated to the remaining performance obligations [Line Items]
Revenue, Remaining Performance Obligation, Amount	$ 32

Revenue and Segment Disclosur_7

Revenue and Segment Disclosures - Long-lived Assets and Total Assets by Geographic Areas (Details) - USD ($) $ in Millions	May 31, 2020	Feb. 29, 2020
Long-lived Assets and Total Assets by Geographic Areas [Line Items]
Long-Lived Assets	$ 1,905	$ 2,546
Assets	3,215	3,888
Canada
Long-lived Assets and Total Assets by Geographic Areas [Line Items]
Long-Lived Assets	356	374
Assets	706	657
United States
Long-lived Assets and Total Assets by Geographic Areas [Line Items]
Long-Lived Assets	1,511	2,132
Assets	2,360	3,071
Other Countries
Long-lived Assets and Total Assets by Geographic Areas [Line Items]
Long-Lived Assets	38	40
Assets	$ 149	$ 160

Cash Flow and Additional Info_3

Cash Flow and Additional Information - Interest and Income Taxes Paid (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2020	May 31, 2019
Supplemental Cash Flow Information [Abstract]
Interest paid during the year	$ 6	$ 6
Income taxes paid during the year	0	1
Proceeds from Income Tax Refunds	$ 1	$ 2

Additional Information - Additi

Additional Information - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	May 31, 2020	May 31, 2019	Feb. 29, 2020
Supplemental Cash Flow Information [Abstract]
Percentage of cash and cash equivalents denominated in foreign currencies	12.00%		12.00%
Percentage of accounts receivable denominated in foreign currencies	11.00%		17.00%
Percentage of accounts payable denominated in foreign currencies	32.00%		17.00%
Interest rate	3.75%		3.75%
Percentage of cash, cash equivalents and investments threshold used to determine major issuer	12.00%	8.00%
Derivative asset, fair value of collateral			$ 1
Derivative liability, fair value of collateral	$ 2
Cash, Cash Equivalents And Investments	955		$ 990
Government subsidies	$ 9